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Abstract 
Mycobacterium avium (M. avium) is quickly becoming the most prevalent 
Mycobacterium infection in western countries. M. avium is an opportunistic pulmonary 
pathogen, infecting patients who often are vulnerable due to existing medical 
conditions. Antibiotic therapy of M. avium is long (generally 18 months) and often 
unsuccessful at eliminating the infection, promoting resistance to commonly used 
antibiotics, such as clarithromycin.  
M. avium exists as a biofilm in lung infections, adding to the difficulty in eradicating the 
infection. My research investigated potential M. avium biofilm dispersing agents, as well 
as antibiotic synergy for improved M. avium eradication. 
Our findings show that ten clinically isolated M. avium samples were all highly resistant 
(>16μg/mL) to antibiotics commonly used in the treatment of M. avium infections, both 
in planktonic and biofilm phenotypes. Some isolates were found to have MICs of 
>128μg/mL. 
M. avium isolates differed in biofilm phenotype, and correspondingly, their susceptibility 
to antibiotics and potential biofilm dispersing agents.  
No antibiotics tested during this research had significant bactericidal or bacteriostatic 
action on any M. avium isolates, in planktonic or biofilm phenotype.   
The addition of 3.6mg/mL aspirin (acetylsalicylic acid) or 3.6mg/mL ibuprofen to 
planktonic and biofilm cells showed significant increase in M. avium cell death. 
Previously identified biofilm dispersing agents, such as mannitol, N-acetyl-L-cysteine, 
active manuka honey, methylglyoxal, Lipitor®, 2,4-dinitrophenol and EDTA,  had no 
significant effect on dispersing M. avium biofilms or increasing their susceptibility to 
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antibiotics. A concentrations of 4mg/mL aspirin combined with 8mg/mL of EDTA had 
significant effects, sterilizing and completely eradicating in vitro three week old mature 
M. avium biofilms. 
Future work should be conducted into the specific pathways aspirin and ibuprofen 
effect. Furthermore, development of effective agonists/antagonists of those pathways 
to disperse M. avium biofilms should be researched. Research into improved and novel 
Mycobacterial antibiotics are needed to develop drugs capable of successfully treating 
M. avium infections.  
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Chapter One 
1. Literature Review and Introduction 
 
1.1 Introduction   
There are over 120 species of Mycobacterium known, including some of the most 
infectious pathogens (Zakham et al., 2012). Mycobacterium tuberculosis (M. 
tuberculosis) is the cause of the devastating disease tuberculosis, however, other clinical 
species of Mycobacteria such as Mycobacterium avium (M. avium) and Mycobacterium 
intracellulare (M. intracellulare) also exist, and are gaining more attention for their 
emerging pathogenicity. 
 
These two non-tuberculosis Mycobacterium often co-exist, and are extremely difficult to 
distinguish between. They are often studied in unison, and are referred to in literature 
as the M. avium complex (MAC). MAC are opportunistic pulmonary pathogens (Flores et 
al., 2005) which commonly infect immunologically compromised individuals or patients 
with prior lung damage (Thoen et al., 1981). M. avium is globally distributed, and 
isolates have been obtained from fresh and salt water as well as soils, house dust, 
bedding and rain water tanks (Inderlied et al., 1993; Starkova et al., 2013).  MAC can 
infect both humans and animals, however, it has been suggested that it cannot easily be 
transmitted between humans due to its ubiquitous distribution and low clinical infection 
rate (Edwards et al., 1969; Thoen et al., 1981). 
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1.2 Mycobacterium avium  
 
The Mycobacterium genus have an unusual cell wall composition, made up of long-chain 
mycolic acids and high G+C content DNA (Stinear et al., 2004), as well as unique lipids 
such as lipoarabinomannan and trehalose dimycolate (Banerjee et al., 2011; Ingen et al., 
2012). This hydrophobic cell wall makes permeability of antibiotics difficult and thus is a 
crucial factor in Mycobacteria drug resistance (Bosne-David et al., 2000). M. avium is a 
gram-positive, slow growing organism (Starkova et al., 2013), reaching a stationary 
phase (concentration of 10⁸- 10⁹cfu/mL) in Middlebrook 7H9 media after seven days (Do 
et al., 2014). Colony growth in M. avium can be observed as smooth or rough colonies, 
with the rough phenotype correlating to increased resistance to antibiotics (Ingen et al., 
2012).  The main source of MAC infection is thought to be from infected domestic birds, 
hence the species name “avium” (Kaevska et al., 2011).  
 
1.3 Diagnosis of MAC and Mycobacterium avium 
For fully confirmable results colonies can take up to two weeks for substantial growth, 
which provides opportunity for contamination (Wu et al., 2009). Identification of MAC 
infections are diagnosed via microbiological data, histopathic studies and observation of 
their pigment and growth characteristics (Wu et al., 2009). The inefficient turnaround 
time for positive identification of Mycobacteria, however, resulted in efforts to find a 
faster diagnostic technique (Bensi et al., 2013). In research today, the identification of 
MAC is most commonly performed via polymerase chain reaction (PCR) methods, where 
M. avium and M. intracellulare can be separately identified. In mycobacterial genomes, 
an insertion element called the IS region is particularly important for effecting the 
virulence of infectious species. IS regions are mobile DNA elements, roughly 1.5kb long, 
repeated throughout the genome, which encode for a transposase enzyme (Stinear et 
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al., 2004). They are often seen throughout bacterial species suggesting that they are 
easily exchanged between bacteria, however, in some mycobacterial species, they have 
remained conserved and can therefore be successfully used as identifying markers for 
species and sub-species (subsp.). MAC can be identified through IS regions IS901, IS1245 
and IS1311 (Stinear et al., 2004), and further classified into sub species of M. avium by 
the identification of IS regions. M. avium subsp. hominissuis contain several copies of 
IS1245, but lack IS901, whereas M. avium subsp. avium contain only one copy of IS1245, 
but multiple copies of IS901 (Guerrero et al., 1995; Johansen et al., 2007; Domingos et 
al., 2009; Kaevska et al., 2011). Several other studies have also shown that other genetic 
markers can be used in the identification of MAC such as housekeeping genes, gyrA, 
gryB (Fukushima et al., 2003) and hsp65 (Bensi et al., 2013) as well as 16S-23S internal 
transcribed spacer (ITS) region, and 16S ribosomal RNA (rRNA) gene (Wu et al., 2009; 
Radomski et al., 2010 Hashemi-Shahraki et al., 2013). Molecular targets DT1 and DT6 
have also been used to identify M. avium (Iamsawat et al., 2010).   
 
1.4 Mycobacterium avium Infection, Aetiology and Pathophysiology  
In New Zealand, MAC infections are the most common non-tuberculosis infections 
(Freeman et al., 2007). Common symptoms of a MAC infection include cough, fever and 
weight loss, which are similar to other Mycobacterium infections (Tran et al., 2014). 
MAC organisms can be isolated from sputum samples and have been described 
frequently as a low-grade infection, colonizing the lungs rather than becoming a true 
disease (Interlied et al., 1993). However it is suggested that in developed countries 
where tuberculosis occurrence is low, MAC infections can be more common and lead to 
death if left untreated (Tran et al., 2014). M. avium has also been isolated from 
broncho-alveolar lavage, bone marrow, faeces and blood samples (Bensi et al., 2013). 
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The primary route of MAC infection in AIDS patients is the intestinal tract (Klatt et al., 
1987; Wallace & Hannah, 1988) followed by the respiratory tract (Agins et al., 1989). 
MAC can also cause soft tissue infection and lymphadenitis, especially in patients under 
the age of five, which can result in surgical removal of the cervical lymph nodes 
(Freeman et al., 2007; Kaevska et al., 2011). This drastic procedure is often the last 
resort when the MAC infection does not respond to antibiotic treatment methods (Wu 
et al., 2009). Left untreated, MAC infections eventually disseminate throughout the 
host. Unfortunately, due to its low person-to-person transmission rate, research into 
MAC infections and their effective treatment has often been side-lined (Wu et al., 2009).  
 
1.5 Mycobacterium avium Incidence  
MAC infection occurs more commonly in adults (Inderlied et al., 1993) especially in 
elderly patients, and more frequently in women than men (Freeman et al., 2007). MAC 
infection is also more prominent in Caucasian ethnicities than any other (Inderlied et al., 
1993). The species composition of MAC populations in patients appears to differ based 
on environment (Inderlied et al., 1993). The most common source of MAC infection 
seems to be from inhalation or ingestion of water (Radomski et al., 2010). MAC has been 
isolated from water filtering systems, hospital water supplies, drinking water supplies, 
and natural aquatic ecosystems (Radomski et al., 2010).  
Before the emergence of AIDS, chronic lung infection was the most common symptom 
of MAC infection and only a handful of MAC cases were reported throughout the 1940’s-
1960’s. (Feldman et al., 1943; Crow et al., 1957; Lewis et al., 1960). Although the human 
to human transmission factor is low, MAC infections are more prevalent among AIDS 
patients and patients with previous lung damage (Freemen et al., 2007). It is also 
suggested that HIV-infected patients who do not succumb to other illnesses will 
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eventually die due to disseminated MAC infection (Chaisson et al., 1992; Nightingale et 
al., 1992). Patients with hairy cell leukaemia, cystic fibrosis (Kilby et al., 1992) and 
previous pulmonary disease are also more frequently infected with MAC (Bennett et al., 
1986; Bouza et al., 1978; Etzkorn et al., 1986). Patients with suppressed immune 
systems, such as organ transplant patients, are also at risk of MAC infection (Wu et al., 
2009).  
 
1.6 Treatment of Mycobacterium avium 
Several antibiotic agents are currently used to combat MAC infections, however, in 
depth studies into the minimum inhibitory concentration (MIC) of antibiotics and 
synergy between antibiotics that are clinically used to treat M. avium infections are 
lacking.  
Drug therapy is the most common treatment of M. avium infections, yet it is an 
extremely long treatment course, that consists of several months of therapy, often with 
reoccurrence of the infection towards the end of the course. Ingen et al. (2012) reports 
that a recommended regime is a macrolide, ethambutol, and rifampicin administered 
over 18-24 months, with potential use of amikacin for the first 3-6 months. This is 
undesirable due to the toxicity and potential side effects from pro-longed antibiotic use.  
 
1.7.1 Antibiotic MICs Against Mycobacterium avium 
Clarithromycin and azithromycin are both effective macrolides against Mycobacteria 
(Inderlied, & Salfinger, 1995) with clarithromycin being the most commonly used 
primary antibiotic to treat M. avium (Park et al., 2009). However, patients receiving long 
term macrolide treatment report resistance to macrolides occurring during therapy 
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(Meier et al., 1994; Nash & Inderlied, 1995; Wallace Jr et al., 1996). Park et al., (2009) 
showed that out of 56 M. avium isolates tested, three isolates had MIC’s of over 
64μg/mL - although the majority had MICs of below 2μg/mL (53 out of 56). Similarly, 
Inagaki et al. (2011) showed that out of 245 isolates, 219 strains were clarithromycin 
susceptible with broth MICs of under 8μg/mL, while 26 strains had MICs of over 
32μg/mL. Lee et al. (2011) determined that the clinically significant resistance to 
clarithromycin is an MIC above 32μg/mL. Clarithromycin has shown to be effective 
against M. smegmatis, M. avium and M. tuberculosis, potentially suggesting that they 
share a similar active site (Bosne-David et al., 2000). Although clarithromycin is shown to 
currently be the most effective antibiotic against M. avium, monotherapy will lead to 
the development of resistance bacteria and more efficient multidrug- therapy regimes 
need to be investigated (Inagaki et al., 2011).  
In a study conducted by Homach et al. (2013) the MIC₉ₒ of antibiotics against 58 M. 
avium isolates grown in MGIT were determined. MIC₉ₒ was defined as the antibiotic 
concentration needed to inhibit 90% of the isolates. Clarithromycin was again found be 
the most effective antibiotic against M. avium, while Ofloxacin was found to be 
potentially ineffective at treating MAC infections (Homach et al., 2013). 
Table 1. MIC₉ₒ results from Homach et al. (2013). 
Antibiotic MIC₉ₒ (μg/mL) 
Amikacin ≤20 
Clarithromycin ≤4 
Ethambutol >25 
Moxifloxacin ≤2 
Ofloxacin >10 
Rifabutin ≤2 
Rifampicin >10 
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Homach et al. (2013) admit that in vitro data into M. avium drug susceptibility is severely 
lacking, with non-uniform methods of MIC analysis, and little research into the 
synergistic properties of combining antimycobacterial drugs. These reasons could 
account for the lack of uniform MIC’s recorded for M. avium. Due to the wide variety of 
MIC values determined for M. avium isolates, Heifets (1988) suggested that extremely 
resistant isolates had broth MIC values of greater than 16μg/mL.  
Ethambutol has also been used in the effective treatment of the MAC complex (Hoffner 
et al., 1987) with evidence to suggest that it inhibits arabinan biosynthesis and disrupts 
the arabinogalactan structure within the cell wall (Takayama & Kilburn, 1989: Mikusovà 
et al., 1995). Other studies suggest that ethambutol also has non-lethal effects which 
can alter cell wall permeability. (Bosne-David et al., 2000). However, liver and vision 
problems are associated with long term ethambutol treatment. Jadaun et al. (2007) 
determined that only 35% of M. avium isolates tested had MICs of 4μg/mL. However, no 
direct data has been provided comparing in vitro MIC results to actual clinical outcomes 
(Homach et al., 2013).  
Isoniazid is commonly used in the treatment of tuberculosis, although its activity against 
M. avium is not as effective, as well as isoniazid having hepatotoxic effects and being 
poorly tolerated by some patients reduces its potential use in MAC infections (Primm & 
Franzblau, 2007). 
Fluoroquinolones, such as moxifloxacin and ciprofloxacin, are also commonly used in the 
treatment of Mycobacterium. Their activity is against the bacterial enzyme DNA gyrase, 
inhibiting the separation of DNA strains and thus cell replication.  
Amikacin is a last resort aminoglycoside, used when all other antibiotics have failed in 
MAC treatment. It causes permanent ototoxicity and thus is not commonly used, to 
avoid this side-effect. Amikacin binds to the 30s bacterial ribosomal subunit causing 
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messenger RNA (mRNA) to be misread, corrupting protein synthesis. Brown-Elliot et al. 
(2013) studied the in vitro MIC of amikacin against MAC isolates. Of the isolates 96.2% 
had MICs of ≤32μg/mL, however, this data was across MAC isolates and not specifically 
for M. avium isolates. Interestingly, increased exposure to amikacin resulted in a 
repeatable point mutation (A to G) at position 1408 within the 16S rRNA of all MAC 
isolates (Brown-Elliot et al., 2013). Ingen et al. (2012) showed that with the addition of 
clofazimine (often used as a replacement for rifampicin in MAC infections), showed 
synergy with amikacin, reducing the MIC of MAC isolates from above 16μg/mL, to 
4μg/mL. 
  
1.7.2 Antibiotic Resistance in Mycobacterium avium 
MAC is resistant to most traditional antimycobacterial agents such as those used to treat 
tuberculosis (Mizuguchi et al., 1983; Good, 1985; Primm & Franzblau, 2007; Tran et al., 
2014). The complex cell wall structure aids in antibiotic inhibition (Rastogi et al., 1989; 
Rastogi et al., 1990) as well as the ability of MACs to produce three types of lactamases 
(Mizuguchi et al., 1985), making them resistant to classical β-lactam class antibiotics 
(Flores et al., 2005). MAC isolates from infected AIDS patients were found to be more 
resistant to antibiotics than other isolates from non-AIDS patients (Inderlied et al., 
1993). 
The maintenance of the cell wall is attributed to Mav2520 and pks12, and disruption of 
these genes leads to increased permeability of the cell wall and increases the 
susceptibility of M. avium bacteria to lipophilic antibiotics (Ingen et al., 2012). The 
discovery of polyketide synthase (Pks12) in M. avium strains has been shown to increase 
drug resistance. Matsunaga et al. (2012) showed that Pks12 is positively correlated with 
drug tolerance and also suggest that Pks12 mediates drug resistance through 
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intracellular drug accumulation. It is well known that mutations in the 23S rRNA can 
affect membrane permeability (Lee et al., 2011) and transmembrane proteins, such as 
drug efflux pumps which are associated with bacteria resistance (Fierro et al., 1988; 
Coleman et al., 1994). Ingen et al. (2012) reported the finding of drug efflux pumps, 
suggesting that are found across all Mycobacteria species, and confer resistance to 
rifampicin, tetracyclines, and macrolides. In M. avium isolates with high levels of 
resistance to clarithromycin, point mutations at 2058 or 2059 within the V domain of the 
23S rRNA gene have been identified (Inagaki et al., 2011; Christianson et al., 2013). This 
is similar to macrolide resistance associated with point mutations at 2275 or 2275 within 
the 23S rRNA gene in M. intracelullare (Iamsawat et al., 2010). The genome of M. avium 
is circular and comprised of single stranded DNA, approximately 5.4 x 106 base pairs (bp) 
in length (Inderlied et al., 1993). However, extra chromosomal DNA in self-replicating 
plasmids are common in MACs. (Crawford et al. 1984; Crawford et al. 1986). An 
insertion sequence in these plasmids was reported in antibiotic resistant pathogenic M. 
avium strains (Kunze et al., 1991) while this insertion sequence was absent in non-
resistant strains. 
The use of non-lethal, cell wall-disrupting factors have provided a way around drug 
resistance, acting by disrupting the layering of cell wall components. This was 
demonstrated by Bosne-David et al. (2000) who reversed clarithromycin resistance in M. 
tuberculosis through the addition of sub-inhibitory cell wall inhibitors. Reduced 
concentrations of antibiotics, although sub-lethal, may influence the components of the 
cell wall, and therefore reduce cell competence leading to eventual cell death (Bosne-
David et al., 2000).  
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Despite the increasing resistance and presence of highly macrolide resistant M. avium 
isolates, no new drugs targeting Mycobacteria have been developed since the 1960s 
(Primm & Franzblau, 2007).  
1.8 Biofilms  
It is surmised that in nature, bacteria do not freely exist in planktonic populations. 
Rather, they survive via aggregating together and forming a community surrounded by a 
matrix of polysaccharides, protein and extracellular DNA (Estrela & Abraham, 2010; 
Islam et al., 2012) which allows the community of bacteria to adhere to a surface 
(Taraskiewicz et al., 2013). This biofilm formation is a survival mechanism for bacteria in 
natural environments, which offers protection against environmental conditions as well 
as enhanced gathering of nutrients in sub-optimal conditions (Hall- Stoodley et al., 
2004). Biofilms are dynamic, constantly moving to allow aeration and nutrient gathering 
to all members of the biofilm population which can be comprised of a single species, or 
a community of micro-organisms (Islam et al., 2012; Taraskiewicz et al., 2013). The 
extracellular matrix of the biofilm in pathogenic, biofilm forming bacteria allows for 
defence against a host’s immunological response, and chronic infection with biofilms 
causes a similar response as inflammation and tissue damage (Islam et al., 2012). 
Biofilms are often formed in response to environmental stresses (Geier et al., 2008).  
 
1.8.1 Biofilm Formation 
The formation of biofilms can be grouped into three stages. The first stage begins when 
planktonic cells attach to a surface. Following this, the cells begin to form an 
extracellular matrix which cause clumping of single cells into aggregates (figure 1). 
Studies have shown that at this early biofilm stage antibiotics are still effective in 
clearing the aggregating cells and prevent development of mature biofilms (Taraskiewicz 
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et al., 2013). After attachment and aggregation, biofilm maturation occurs, with the cells 
shifting from a planktonic to sedentary lifestyle (Islam et al., 2012).  
However, after the three stages of biofilm formation, detachment occurs. This is when 
bacteria cells within the biofilm are released and return to a planktonic lifestyle, often 
forming biofilms where they come into contact with another un-colonised surface 
resulting in disseminated infection in patients. 
Biofilm formation occurs via cell signalling, or quorum-sensing (QS). QS occurs when a 
threshold concentration of an autoinducer (AI), a molecule or small peptide, is reached 
and planktonic cells begin to adhere to a surface and change gene expression to 
promote biofilm conditions (Schuster et al., 2003; Taraskiewicz et al., 2013). The most 
studied AIs include autoinducer-1 and -2 (AI-1, AI-2), N-acyl-L-homoserine lactones 
(AHL1-6) or small AI peptides (AIP) (Estrela & Abraham, 2010). Due to the nature of 
biofilms generally being a mixed species population, QS molecules and AIs can be 
detected across a wide range of bacterial species (Keller & Surette, 2006). QS in bacterial 
populations is extremely complex, with multiple regulatory pathways being involved 
(Wagner et al., 2004). QS has been implicated as the same mechanism that reverses the 
formation process, promoting biofilm dispersal (Taraskiewicz et al., 2013). This 
complexity may explain why previous studies into blocking QS mechanisms does not 
completely eradicate biofilm formation.  
12 
 
 
Figure 1. Moholkar, K. & Ziran, B. Illustration of the biofilm bacterial colonization process. From Vermeer 
and the invention of seeing (p. 572) by Bryan Jay Wolf, 2006, Rockwood & Green’s Fractures in Adults 6th 
Ed. Philadelphia: Lippincott Williams & Wilkins. 
1.8.2 Biofilms in Clinical Settings 
The clinical significance of biofilms is becoming more widely recognised as a hindrance 
to the effective treatment of bacterial infections. Both antibiotic resistance and the 
ability to continuously re-infect patients can be attributed to the formation of biofilms 
(Keays et al., 2008: Estrela & Abraham, 2010). Such developments in cystic fibrosis, 
(Keays et al., 2008) have shown that antibiotic resistance of respiratory infections plays 
a vital role in the chronic reinfection and inability to eradicate infection.  The formation 
of biofilms on diverse surfaces such as implants, contact lenses, medical devices, 
wounds, lung epithelium and other tissues (Ramage et al., 2007; Islam et al., 2012), 
means that biofilms have become increasingly prevalent within clinical settings and can 
prove to be challenging and costly to treat. Catheters are a potentially dangerous source 
of infection with biofilms colonising tubes that feed directly into the host (Falkinham, 
2007) and resisting any antibiotic effort to clear them. The release of planktonic cells 
through dispersal phase of a biofilm can be effectively treated, however, actual 
eradication of a biofilm within a patient is rarely achieved (Taraskiewicz et al., 2013). It 
has also been shown that planktonic cultures have a much lower resistance to 
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antibiotics with biofilms showing between 10-100 fold increases in resistance (Keays et 
al., 2008).  This suggests that original MIC’s of broth cultivated bacteria is inaccurate in 
representing actual dosage required to treat infections in vitro. Although it is still largely 
unknown why biofilms exhibit much higher MICs (Estrela & Abraham, 2010), it has been 
shown that cystic fibrosis patients who received antibiotics which fought biofilm 
formation had improved clinical outcomes (Keays et al., 2008). 
 
1.8.3 Antibiotic Resistance Mechanisms of Biofilms 
Physically, biofilms provide natural antibiotic resistance purely via ‘safety in numbers’ as 
seen below (figure 2). Extracellular matrix results in a slower penetration of antibiotics, 
allowing bacterial cells to elicit stress responses such as up-regulation of antibiotic pump 
expression (McNabe et al., 2011) and effectively avoid antibiotic induced cell death. 
Furthermore, the microenvironment within the biofilm is altered, thus altering 
conditions at which the antibiotics interact with bacterial cells. Subtle changes in pH, 
temperature and oxygen availability can affect the kill rate of antibiotics (Taraskiewicz et 
al., 2013). These three mechanisms allow for the development of biofilm persister cells 
that lead to redevelopment of biofilms after antibiotic treatment. It is suggested that 
these persister cells exist in particularly nutrient depleted parts of the biofilm,and in 
their starved state, adopt a dormancy-like stationary metabolism that is highly resistant 
to antibiotics (as most antibiotics act on actively dividing cells) (McNabe et al., 2011; 
Taraskiewicz et al., 2013). 
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Figure 2. Chambless et al., (2006), Four possible mechanisms of biofilm antibiotic resistance, Retrieved 
January 6, 2015, from Journal of Applied Environmental Microbiology website: 
http://aem.asm.org/content/72/3/2005/F1.expansion.html 
This structure of a biofilm plays a vital role in their antibiotic resistance and especially to 
high dosages of drugs (Estrela & Abraham, 2010). The control of biofilms can be 
separated into three categories; Metabolites interfering with the stabilization and 
formation of biofilms by interfering with AIs; the addition of cleaving-enzymes that 
compromise the polysaccharide and/or DNA elements of the biofilm matrix; and the 
disruption of biofilm formation signalling molecules that cause dispersal of the biofilm, 
reverting cells back into a planktonic lifestyle (Estrela & Abraham, 2010).  
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1.8.4 Biofilm Dispersal Agents 
Recent focus has also shifted onto compounds that cause biofilm dispersal, especially in 
clinical settings where biofilms have emerged as being extremely difficult to treat. A 
non-toxic biofilm dispersing agent which would be able to be pumped through catheters 
to clear and prevent biofilms would demonstrate extreme efficiency in hospitals. The 
development of biofilms on implants is also a great hindrance to patients, and an orally 
taken biofilm dispersing agent could greatly decrease the post-operation complications 
with implants.  
Nitric oxide (NO) has been found to disperse biofilms in gram-positive bacteria- 
particularly in Psuedomonas aeruginosa (P. aeruginosa) (Nabloa et al., 2005; Schlag et 
al., 2007; Hetrick et al., 2009). The addition of chelating agents, such as 
ethylenediaminetetraacetic acid (EDTA), have been shown to have some biofilm 
dispersing activity (Ramage et al., 2007; Liaqat et al., 2010; Robertson et al., 2012; 
Cavaliere et al., 2014). Acetylsalicylic acid (aspirin) combined with EDTA showed 
dramatic effects on established P. aeruginosa biofilms, completely eradicating existing 
biofilms (Al-Bakri et al., 2009). N-acetyl-L-cysteine and ibuprofen were shown to 
decrease biofilm formation in Escherichia coli (E. coli) strains (Naves et al., 2010). Certain 
fatty acids have also been found to possess biofilm dispersal capabilities across species, 
and interestingly, induce biofilm dispersal in species that do not intrinsically produce 
these fatty acids (Davies & Marques, 2009). Several fatty acids from the opportunistic 
pathogen Stenotrophomonas maltophila have been found to be diffusible signalling 
factors (DSF) that caused a reduction in biofilm formation, and inhibited swarming in 
mixed-culture populations (Huang & Wong, 2007). In addition to this, enzymes have also 
been explored for their antibiofilm properties. The addition of DNase I to P. aeruginosa 
biofilms in cystic fibrosis patients showed a decrease in thickness of the sputum, and is 
thought to act on the extracellular DNA exposed in the biofilm matrix, weakening the 
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biofilm (Whitchurch et al., 2002).  Lysostaphin, an endopeptidase, was also found to 
effectively penetrate biofilms of Staphylococcus aureus (S. aureus) and Staphylococcus 
epidermis (S. epidermis) (Walencka et al., 2005; Kokai-Kun et al., 2009; Belyanksky et al., 
2011). Alpha-amylases were also found to have anti-biofilm activity on S. aureus 
(Craigen et al., 2011). Alginate lyase, and lactonase were reported to cause liquefaction 
of P. aeruginosa biofilm matrixes (Alkawash et al., 2006; Kiran et al., 2011). Mannitol at 
10-40mM concentrations was found to revert persister cell phenotype in P. aeruginosa, 
increasing their sensitivity to tobramycin by up to 1,000 fold (Barraud et al., 2013).  
Furthermore, attempts have been made to combine quorum-quenching compounds 
with antibiotic treatment for biofilms. The purpose of these attempts were to prevent 
single cells from disseminating and re-establishing a biofilm. Although the host immune 
system should recognise and effectively destroy single pathogenic cells, underlying 
conditions that lead to the biofilm formation, such as autoimmune diseases and 
previous lung damage often means that the body is not capable of clearing biofilms 
(Estrela & Abraham, 2010). Quorum- quenching compounds prevent the accumulation 
and eventual biofilm formation of planktonic cells by disrupting QS. Several compounds 
have been identified through previous studies such as patulin and penicillic acid which 
greatly increase sensitivity of P. aeruginosa to conventional antibiotics (Wagner et al., 
2004; Abraham, 2005; Liaqat et al., 2010). El-Mowafy et al. (2014) found aspirin to be 
effective at inhibiting QS pathways in P. aeruginosa which lead to a decrease in the 
pathogens virulence and biofilm formation. Furthermore, the surfactant protein, PLUNC, 
has been found to be able to inhibit the formation of P. aeruginosa biofilms in vitro 
(Gakhar et al., 2010). 
Although the identification of biofilm dispersing agents has progressed, many of these 
compounds are specific for certain species of bacteria, and cannot be generalised to 
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other species. Compounds that cause detrimental effects in one species of bacteria may 
enhance the antibiotic resistance in another, therefore careful study of each potential 
biofilm dispersing agent must be conducted. Furthermore, many compounds which 
prevent biofilm formation have been identified, but have no clinical significance as they 
are ineffective at treating existing mature biofilms (Estrela & Abraham, 2010). The 
complexity of biofilm metabolism and regulation has been studied in few bacterial 
species, and even so, is not completely understood.  
 
1.8.5 Biofilms in Mycobacterium avium 
Previous research has uncovered the major role of biofilms in bacterial resistance. The 
aggregation of cells within a matrix provides many advantages. One being antibiotic 
resistance, with the share size of a biofilm acting as a barrier to the innermost cells 
preventing antibiotics from reaching the innermost cells. It has been shown that MAC 
occupies biofilms in nature and infection (Carter et al., 2003; Ingen et al., 2012). In a 
study investigating M. avium resistance and biofilm growth in catheters conducted by 
Falkinham (2007) it was observed that there was an increase in antibiotic resistance of 
M. avium grown in biofilms compared to planktonic M. avium grown in suspension. This 
supports previous research into increased drug resistance in biofilm phenotype. McNabe 
et al. (2011) found that both sub-inhibitory concentrations of streptomycin and 
tetracycline increased biofilm formation of M. avium grown in vitro, and could possibly 
exacerbate MAC infection in patients receiving antibiotic treatment with these drugs. In 
contrast, their study found that ampicillin, moxifloxacin and rifampicin has no effect on 
biofilm growth. McNabe et al. (2011), found that biofilm formation in M. avium 
conferred resistance to clarithromycin and ethambutol, both antibiotics that are used as 
primary drugs in MAC infection. Falkinham (2007) surmised that the physical defence of 
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a biofilm is not the cause of antibiotic resistance, but prolongs the time it takes 
antibiotics to reach the cells. This allows time for physiological changes within the M. 
avium cells to occur, conferring antibiotic resistance to the cells. This agrees with other 
research which suggests that the naturally slow growing M. avium is further stunted in a 
biofilm phenotype, increasing the individual cells resistance to antibiotics by reducing 
their metabolism (Ingen et al., 2012). Interestingly M. smegmatis biofilms, which are 
thought to share many characteristics with M. avium biofilms, have a strict dependence 
on extra-cellular iron to form biofilms (Islam et al., 2012).  
 
1.8.6 Biofilm Genetics 
It is estimated that roughly twenty percent of bacterial genes are expressed differently 
in biofilms (Schuster et al., 2003; Estrela & Abraham, 2010) which could explain the 
difficulties in exploring the communication within, and regulation of biofilms. Due to 
development of high throughput sequencing, the ability to mine genome and 
transcriptomes for genes and RNA involved in biofilm processes has become more easily 
accessible. Little research into the gene pathways that effect biofilm formation in M. 
avium currently exists. 
 
1.8.7 Biofilm Genetics Within Mycobacterium avium 
The regulator LysR has been associated with biofilm formation in M. avium (McNabe et 
al., 2011). LysR has been found to regulate the synthesis of mycolyldiacylglycerol (Islam 
et al., 2012). It has also been found that mutant M. avium lacking specific attachment 
genes are unable to form biofilms on epithelial cells of rats or PVC surfaces (Yamazaki et 
al., 2006). Biofilm formation related genes guaB2, and gtf have been identified in 
previous studies, and are associated with glycopeptolipid (GPL) and lipoarabinomannan 
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(LAM) production – both are compounds used in M. avium cell wall synthesis (Freeman 
et al., 2006; Yamazaki et al., 2006; McNabe et al., 2011). M. avium isolates with mutant 
GPL had reduced biofilm formation but no adverse effect on planktonic populations 
(Yamakazi et al., 2006). Yamazaki et al. (2006) identified three hypothetical membrane 
transport proteins (tmptA, tmptB and tmptc) in M. smegmatis, which are also highly 
conserved in M. avium and have a proposed function in transporting precursor GPL 
proteins from the inner membrane. Deletion of tmpt gene cluster resulted in impaired 
biofilm function in M. smegmatis (Yamakazi et al., 2006). Geier et al. (2008) showed that 
AI-2, when added to planktonic M. avium cultures, induced a biofilm phenotype. 
However, they suggested that conversely to other research, AI-2 did not affect QS in M. 
avium, rather causing biofilm formation due to inducing an oxidative stress response. 
Currently there is no research into potential detachment mechanisms, mechanisms for 
antibiotic resistance, and little research into signalling or metabolic pathways associated 
with M. avium biofilms.   
 
1.9 Methodology 
Colorimetric methods are often used to visually identify active metabolising cells. 
For example 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride (STC), is an oxidation-
reduction dye that has been used in previous experiments for accurate identification of 
positive culture growth, and for drug susceptibility testing (Park et al., 2009). The 
molecule does not affect M. avium growth or antibiotic activity, but produces a dark 
pink precipitate via cell growth therefore effectively showing active cell metabolism.  
Similarly, the reduction of yellow 2,3,5 triphenyltetrazolium chloride (TTC) to 
triphenylformazan (TPF) produces a colour change from colourless to red in viable cells 
(Mohammadzadeh et al., 2006; Rodrίguez et al., 2011). This allows rapid and accurate 
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detection of viable cells under observation through a microscope, and has already been 
used in previous M. avium and bacterial MIC studies (Rodrίguez et al., 2011).   
Ethidium monoazide (EMA) has been commonly used with Mycobacteria to visually 
differentiate between live/dead cells. In bacterial cells EMA is only able to bind to 
chromosomal DNA of dead bacteria (Riedy et al., 1991; Takashi et al., 2009). Ethidium 
bromide (EtBr) also performs this function and is able to be used to visualise live/dead 
bacteria. However, unlike EMA that irreversibly binds to the DNA (Nogva et al., 2003; 
Rudi et al., 2005), EtBr reversibly intercalates with DNA in dead cells and therefore cells 
have to be visualised as soon as possible to retain accurate results (Tomchick & Mandel, 
1964; Waring, 1965).  
 
MTT (3-(4,5-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and XTT (2,3-bis-(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) are both colometric 
reagents used in colometric assays - particularly to asses cell viability (Mohammadzadeh 
et al., 2006; Singh et al., 2011; Trafny et al., 2013). Both compounds have already been 
used to assess cell viability in Mycobacteria and M. avium (Primm & Franzblau, 2007; 
Singh et al., 2011).The water soluble yellow MTT is reduced to formazan which is an 
insoluble purple crystal by actively metabolising cells (Mshana et al., 1998). A solubilizing 
solution can be added to dissolve the formazan, allowing the absorbance of the 
coloured solution to be analysed on a Broad Smart Spec ™ 3000 spectrophotometer 
(Mosmann, 1983; Mohammadzadeh et al., 2006; Trafny et al., 2013). XTT is often used 
over MTT due to the reduced XTT being water soluble therefore eliminating the need for 
a solubilising solution (Primm & Franzblau, 2007).  
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1.10 Research Objectives 
The objective of this research is to investigate possible options in the treatment of M. 
avium. This was to be done by conducting experiments into both the antibiotic 
sensitivity of M. avium isolates from the Waikato Hospital, and their response to 
potential biofilm dispersing agents.  
 
1.10.1 Aims 
1) To identify the MIC’s and potential antibiotic resistant strains of M. avium from 
hospital isolates.  
 
2) To identify synergy between antibiotic combinations, and antibiotics with 
potential biofilm dispersing agents, which result in effective sterilization of M. 
avium isolates. 
 
3) To determine the pathways involved with consequential bacterial biofilm 
formation and the effect of previously identified biofilm dispersing agents on M. 
avium.     
 
1.10.2 Hypotheses  
1) Several hospital strains will have increased MICs and increased antibiotic 
resistance in planktonic form. 
 
2) M. avium biofilms will have greatly increased MICs in comparison to their 
planktonically grown counterparts. 
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3) The addition of biofilm dispersing agents to biofilms will reduce their MIC to 
antibiotics. 
 
4) The biofilm dispersing agents will effect gene expression. 
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Chapter Two 
2. Methods and Materials 
 
All following methods were carried out at the Molecular Genetics Laboratory (C.2.03) 
within the University of Waikato under PC1 and PC2 conditions. All techniques were 
carried out using aseptic technique, and all work stations were disinfected with virkon, 
or 70% ethanol and laboratory consumables were disinfected with virkon, trigene, and 
disposed of in accordance to Ministry of Primary Industries (MPI) standard protocol.  
 
2.1.1 Mycobacterium avium Isolate Collection and Preparation 
This research was conducted using 12 M. avium isolates collected from the Waikato 
Hospitals isolate library. All 12 isolates were collected from a wide range of patients 
treated by the Waikato Hospital. The isolates were grown in the Waikato Hospital 
Microbiology laboratory before being transported at room temperature to the 
Molecular Genetics Laboratory (C.2.03) at the University of Waikato. The isolates were 
stored at -4 degrees Celsius (°C) temperatures until the research began.  
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 Isolate Origin 
 Isolate 1: Submandibular lymph node 
 Isolate 2: Submandibular lymph node 
 Isolate 3: Sputum 
 Isolate 4: Sputum 
 Isolate 5: Cervical lymph node tissue 
 Isolate 6: Lesion on neck 
 Isolate 7: Cervical lymph node tissue 
 Isolate 8. Sputum 
 Isolate 9: Unknown 
 Isolate 10: Unknown 
 Isolate 11: Sputum 
 Isolate A: Sputum 
 
2.1.2 Culture Storage Protocol 
All M. avium cultures were stored at -80°C to provide an original stock that could be 
resuscitated and grown up if working cultures became contaminated. In a sterile 15mL 
falcon tube, 0.75mL of sterile glycerol was added to 7.5mL of inoculum provided by the 
Waikato Hospital. This solution was then divided and pipetted into 1.5mL cryotubes and 
stored within a -80°C freezer. 
 
2.1.3 Culture Methods 
All M. avium cultures were grown in 50mL vented tissue culture flasks, using 10mL of 
BHI + 199 + 1/100 ACES buffer media (final pH 6.5). Cultures were subbed into fresh, 
sterile media every 14 days to prevent contamination and to maintain a population of 
actively metabolising cells. All cultures were incubated at 37°C to promote and maintain 
growth, unless otherwise stated.  
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2.1.4 Media Preparation 
All media was prepared using autoclaved 15-18 megohm-cm double distilled deionised 
water (mQH2O) (Barnstead double distilled/deionisation system). All recipes for media 
can be found in appendix one (page 146).  
 
2.2 Antibiotic Preparation 
All antibiotic solutions were reconstituted using autoclaved 15-18 megohm-cm double 
distilled deionised water (mQH2O) (Barnstead double distilled/deionisation system), 
unless stated otherwise. All antibiotic solution recipes can be found in appendix two 
(page 150). All solutions were prepared in 15mL falcon tubes, under sterile conditions 
and filter sterilized using 0.22µm millipore filters and 10mL syringes. 
The antibiotics used in this research were kindly purchased by Noel Karalus from the 
Waikato Hospital. The antibiotics provided were as follows; Klacid ® IV 500mg 
(Clarithromycin); DBL ™ 500mg in 2mL (Amikacin); Augmentin (Co-Amoxiclav);  Rifadin ® 
600mg (Rifampicin); DOXY 100 ™ 100mg (Doxycycline); Aspen Ciprofloxacin 200mg in 
100mL (Ciprofloxacin); Cefoxitin 100mg; Avelox® 400mg (Moxifloxacin); Ethambutol; 
Rifinah ™ (Rifampicin with Isoniazid). 
 
2.3 Biofilm Dispersal Agents Preparation 
All biofilm dispersal agents were prepared using autoclaved 15-18 megohm-cm double 
distilled deionised water (mQH2O) (Barnstead double distilled/deionisation system), 
unless stated otherwise. All recipes for biofilm dispersal agents can be found in appendix 
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three (page 152). All solutions were prepared in 15mL falcon tubes, under sterile 
conditions and filter sterilized using 0.22µm millipore filters and 10mL syringes. 
 
2.4.1 MTT Protocol 
Firstly, 10mLs of 5mg/mL MTT solution was prepared in a 15mL falcon tube and 50mL of 
20% SDS, 50% DMF MTT Solubilising solution was prepared in a sterile 50mL falcon tube, 
as per their recipes found in appendix one (page 147). Fresh MTT was added to the 
culture at a 1:3 volume (e.g. 167µL MTT added per one mL of culture). The MTT was 
pipetted up and down four times to ensure the solutions were thoroughly mixed. The 
culture, plus MTT, was incubated in the absence of light at 37°C for four hours. After the 
four hour incubation, MTT solubilising solution was added to the culture at a 2:3 volume 
(e.g. 666µL MTT Solubilising solution added per one mL of culture). The MTT Solubilising 
solution was pipetted up and down four times to ensure that the solutions were 
thoroughly mixed. Samples were then incubated in the absence of light overnight at 
37°C to ensure complete solubilising of the purple formazan crystals. Sample optical 
density (OD) was then measured on a spectrophotometer to determine the amount of 
formazan present in each sample. 
 
2.4.2 Measuring ODs of MTT Treated Samples 
Sample OD was measured on a spectrophotometer at a wavelength of 570 nanometres 
(nm). A control of one mL sterile media, 167µL MTT and 666µL MTT solubilising solution 
was used to blank the machine. The samples were thoroughly mixed before being 
loaded into curvettes and read at a wavelength of 570nm on a spectrophotometer. The 
spectrophotometer was blanked every five samples to ensure minimal machine error.  
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2.5 Mycobacterium avium Biofilm Cultivation 
In contrast to previous studies using Middlebrook 7H9 media, Brain heart infusion (BHI) 
+199 media was determined to have the greatest rate of M. avium growth, forming 
mature biofilms within three days of sub-culturing, and therefore was used for all 
planktonic and biofilm experiments. A 1/100 dilution of 1M ACES buffer (pH 6.5) was 
added to the BHI +199 media to ensure that any bactericidal or bacteriostatic activity 
was not due to an extreme pH change, caused by an antibiotic, biofilm dispersing agent, 
or solutions made up in dimethyl sulfoxide (DMSO). 
For antibiotic and biofilm dispersal agent experiments, 24 well polystyrene culture 
plates were used to efficiently control large numbers of samples (figure 3). Biofilms were 
cultivated by placing a 12mm sterilized glass coverslip into the bottom of each well to 
aid in the adherence of the biofilms onto the glass surface and promote their growth 
over planktonic growth. One mL of inoculated media was then added to every well. To 
ensure consistency between biofilm and planktonic experiments, planktonic cells were 
also cultured in 24 well plates, without 12mm glass coverslips. Antibiotic or biofilm 
dispersal agents were then added to wells, or to the inoculated media, in order to 
maintain accurate concentrations by reducing pipetting error.  
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Figure 3. Polystyrene 24 well plate used to grow M. avium biofilms. The purple colouration in the wells is 
due to the formation of insoluble formazan crystals during MTT analysis. 
 
2.5.1 Glass Versus Polystyrene  
For effective biofilm formation in following experiments, the best biofilm growth 
promoting surface had to be determined. This was done by measuring the difference in 
growth between the two surfaces, using both MTT and crystal violet staining methods. 
For MTT growth determination a glass or polystyrene bead was placed into a 1.7mL 
sterile eppendorf tube. To the tube 0.1mL of inoculated BHI+199 media was added and 
left to grow over 24 hours at 37°C. After incubation, 16μL of 5mg/mL MTT solution was 
added and mixed thoroughly, then left to continue incubating at 37°C for a further four 
hours. After four hours, 90μL of MTT solubilising solution was added to the solution. 
After mixing well, the tubes were incubated at 37°C overnight and the OD of each 
solution read at a 570nm wavelength via spectrophotometer. A control solution 
repeating all conditions described, however, replacing inoculated media with sterile 
media was also conducted.  
For growth analysis via crystal violet staining, one glass or polystyrene bead was placed 
into a 1.7mL sterile eppendorf tube and 0.1mL of inoculated BHI+199 media was added 
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to each tube, and left to grow over 24 hours at 37°C. After incubation, 100μL of crystal 
violet stain was added and left to develop at room temperature (RT) for 15 minutes. 
Then each bead was washed three times with sterile water, ensuring all of the crystal 
violet stain had been removed. After washing, 1mL of 90% EtOH was added to the tube, 
to dissolve the stain from the attached biofilm cells. The OD of each solution read at a 
570nm wavelength via spectrophotometer, as per recommended in previous research 
(Mshana et al., 1998; Trafny et al., 2013). A solution, replacing inoculated media with 
sterile media was treated in the exact same conditions as described above, and was 
used as a control.  
In both experiments, the control was used as a blank for the spectrophotometer. Both 
experiments were repeated.  
 
2.5.2 Aspirin Longevity Experiment Design 
In each sample, one mL of media was inoculated with 100µL of 1/10 diluted inoculum. 
Then to one sample, 36µL of 100mg/mL aspirin stock solution was added and mixed 
thoroughly. The other sample was left untreated to act as a control. Both samples were 
then incubated over ten days at 37°C. Every day, 100µL was removed from both the 
aspirin treated, and non-treated samples and spread using aseptic technique onto a BHI 
+ 199 + 5% horse serum agar plate. The plates were then incubated at 37°C and checked 
for growth on a daily basis.    
 
2.5.3 Antibiotic Titration  
A dilution series was made from 128µL/mg to 1µL/mg concentration of antibiotics 
according to the following figure; 
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Figure 4. Standard dilution series used to prepare concentration gradients of antibiotics. 
 
2.6 PCR Protocols 
All PCRs were performed using BIORAD T100™ Thermo Cycler PCR machines, and 
reaction mixes made in single 200μl PCR tubes (Axygen). The PCR reaction mixes were 
prepared in a DNA free UV hood, to minimise potential contaminants, DNases and 
RNases. A negative control was prepared in every experiment, replacing DNA with 
DNase and RNase free water. PCR masters mixes were prepared in bulk, aliquoted out 
and frozen at -20°C, and used when needed
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2.6.1 Identification PCR 
All isolates were identified by PCR and gel electrophoresis as to their correct 
classification, using MAI primers (table 2) taken from Tran et al. (2014). One μL of 
genomic DNA was added to 19μL of master mix per PCR reaction tube.  
The cycle used was touchdown PCR, as per below. 
Step Temperature Time 
TAQ activation 95°C 15 minutes 
Cycle x 10 
Dropping 1°C 
Per cycle 
Denaturation 95°C 20 seconds 
Annealing 65°C-55°C 15 seconds 
Extension 72°C 30 seconds 
Cycle x35 Denaturation 95°C 20 seconds 
Annealing 55°C 20 seconds 
Extension 72°C 30 seconds 
Final Extension 72°C 10 minutes 
 
2.6.2 SAUTYPE PCR 
SAUTYPE PCR was then performed to distinguish if there were any genetic differences 
between the isolates and potentially give an explanation for the differences in observed 
phenotype.  
TAQ polymerase was added to the master mix at a ratio of 0.25μL:50μL TAQ polymerase 
to total PCR reaction mix volume. Two μL MB01 Genomic DNA was added to every 18μL 
of master mix. For this PCR, primer concentration was doubled (2μL:50μL primer to total 
volume).  
SAUtype PCR cycle was used as below.  
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Step Temperature Time 
TAQ activation 95°C 15 minutes 
 25°C 5 seconds 
 25°C-60°C Increasing 0.1°C 
per second until 
60°C is reached 
 60°C 30 seconds 
Cycle x2 95°C 60 seconds 
50°C 15 seconds 
50°C-25°C Decreasing 0.1°C 
per second until 
25°C is reached 
25°C-50°C Increasing 0.1°C 
per second until 
50°C is reached 
50°C 30 seconds 
Cycle x 39 95°C 15 seconds 
48°C 60 seconds 
65°C 2 minutes 
Final Extension 65°C 10 minutes 
 
2.6.3 Subtype Identification PCR 
Subtype identification was done using DT1 and IS1311 Primers (table 2), and a PCR cycle, 
adapted from Tran et al. (2014).  
Step Temperature Time 
TAQ activation 95°C 10 minutes 
Cycle x35 Denaturation 95°C 20 seconds 
Annealing 60°C 40 seconds 
Extension 72°C 35 seconds 
Final Extension 72°C 10 minutes 
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2.6.4 Real Time PCR 
Real time PCR was carried out using the Quanta Biosciences qScript™ One-Step SYBR ® 
Green qRT-PCR Kit, and this PCR cycle as follows. 
Step Temperature Time 
TAQ activation 95°C 10 minutes 
Cycle x40 Denaturation 95°C 15 seconds 
Annealing 55°C 15 seconds 
Extension 72°C 20 seconds 
Final Extension 80°C 10 minutes 
 
2.6.4.1 Quanta Biosciences qScript™ One-Step SYBR ® Green qRT-PCR Kit 
Method 
Quanta Biosciences qScript™ One-Step SYBR ® Green qRT-PCR Kit was used for real time 
PCR from the three RNA samples (acquired as per 2.12.2). For a 50μL reaction mix, the 
following quantities apply.  
Reaction Ingredients  Per Reaction Concentration 
One-Step SYBR® Green Master Mix 25μL 1X 
Forward Primer ~ 200-500nM 
Reverse Primer ~ 200-500nM 
Nuclease Free H2O ~ Make up to 50μL 
RNA Template 5-10μL ~ 
qScript One-Step RT 1μL 1X 
 
The reaction mix was prepared in a PCR cabinet with the RNA added to the reaction mix 
in a sterile, RNase free environment. The qRT-PCR was the carried out on a cycle as 
described above. After the qRT-PCR had completed the products were then run out on a 
1% agarose gel as described in 2.7.1 and 2.7.2. 
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2.6.5 Primer Reconstitution 
The primers were reconstituted with TE buffer to give a final concentration of 200pMol, 
and aliquoted into 0.6mL eppendorf tubes, and stored at -20°C. By aliquoting out the 
primers it prevents contamination of the entire primer stock solution and provided 
sterile reserves in case issues arose during PCR. From the 200pMol primer stocks a 
20pMol concentration was made by dilution and was added to the PCR mix.    
 
2.7 Gel Electrophoresis Protocol 
Electrophoresis was used to visualise PCR reactions and determine base pair (bp) 
number of PCR products via the use of a 100bp ladder.  
 
2.7.1 Agarose Gel Preparation 
Into a conical flask 35mL 1X Super Buffer was added before 0.35g of agarose (hyagrose) 
was mixed in to create a 1% agarose gel. The solution was microwaved at medium heat 
for 2 minutes, with occasional stirring to prevent boiling over, in order to melt the 
agarose. Molten agarose gel was cooled via running the conical flask under cold water 
and 2μL of 10mg/mL EtBr was added and mixed thoroughly via stirring. EtBr was added 
for following visualisation and imagine of the gel. The molten agarose gel was then 
poured into a gel rig, well combs added and left to set. Once set, well combs were 
removed.  
 
2.7.2 Gel Electrophoresis 
Previously made, solidified, 1X Super Buffer gel was loaded into a Thermo Fischer 
Scientific ™ Owl Separation Systems ™ small gel electrophoresis tank. Sufficient 1X Super 
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Buffer was added to the tank until the gel was covered with 2-5mL of 1X Super Buffer. 
Five µL of 100bp ladder was added to a well in the gel in order to be able to accurately 
read the correct bp size of resulting PCR products. Approximately 2μL of 6X binding dye 
was mixed thoroughly with 10μL of PCR product before being loaded into a well on the 
agarose gel. Gel electrophoresis tank was sealed and electrodes adjusted so that the 
wells were closest to the negative electrode. Gels were run for 10 minutes at 200V.  
 
2.7.3 Gel Visualisation and Imaging 
After completion of gel electrophoresis, the gel was safely removed from the gel 
electrophoresis tank, and placed onto a UV light box. Under protective conditions, the 
UV light was turned on, and allowed the visualisation of the DNA bands within the gel. 
These were then able to be photographed via a computer program Scion X Imaging, and 
saved for future purposes. All gels were disposed of by soaking in bleach to destroy DNA 
products and autoclaving, as in accordance with MPI protocol.  
 
2.8 Microscopy 
Microscopy was used to physically view M. avium bacteria and assess growth, death and 
viability using stains. A Zeiss Fluorescence Axiostar microscope was used to observe 
samples.    
 
2.8.1 Auramine-O Double Stain Protocol  
Staining protocol was adapted from Ichijo et al. (2010). The supernatant was removed 
from biofilm via sterile pipette, ensuring that the biofilm remains undisturbed and 
intact. A 1mL aliquot of ~2.0% formaldehyde to PBS solution was added to the biofilm 
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and left for 10 minutes. The formaldehyde: PBS solution was removed and 0.5mL of the 
auramine-O stain was added to the biofilm, then left to develop for 15 minutes in the 
absence of light.  The auramine-O stain was removed and biofilm was washed with 1mL 
sterile water. Following the removal of the sterile water, 1mL of acid alcohol methylene 
blue counter stain was added to the biofilm and left to develop in the absence of light 
for 10 minutes. The acid alcohol methylene blue counter stain was then removed and 
biofilm washed with sterile water, so to remove all unused counter stain. The biofilms 
on glass coverslips were then mounted on microscope slides and viewed under blue 
light. 
 
2.8.2 SEM Cell Fixative Preparation 
The supernatant was removed from each well, carefully to not disturb the biofilm 
growing on the glass coverslip. Each sample was washed with 1mL of PBS, again carefully 
to not disturb the biofilm. Then 1mL of 4% gluteraldehyde was added to every sample 
and then incubated at RT for four hours. In order to fix and kill the cells within the 
biofilm, making them safe to work with. Following the incubation, the 4% 
gluteraldehyde was removed and biofilm was washed with 1mL PBS. The biofilm was 
then saturated with 50% EtOH, and left at RT for an hour. The 50% EtOH was then 
removed and replaced with 75% EtOH and left at RT for another hour. This process of 
removing the previous EtOH concentration and saturating the biofilm with another EtOH 
concentration, then leaving for an hour was repeated through 50%, 75%, 90%, 95% and 
finally 100% concentrations of EtOH. Once the biofilm samples had been saturated with 
100% EtOH for an hour, they were ready to proceed to critical point drying technique 
used to prepare samples for SEM imaging. The series of steps increasing the EtOH 
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concentration were carried out in an attempt to replace the H20 within the cells with 
EtOH, essentially fixing them and preserving their structure.  
 
2.8.3 SEM Sample Preparation, Critical Point Drying and Mounting  
Sample preparation, critical point drying, and sample mounting for SEM imaging 
protocol was performed by the University of Waikato’s SEM technician, Helen Turner.  
 
2.8.4 2,3,5 Triphenyl Tetrazolium Chloride Indicator 
Oxidation- reduction indicator TTC is used to identify bacteria metabolism (Rodrίguez et 
al., 2011) with the bacteria showing red under normal lighting conditions at a 
magnification of 40x. The TTC was prepared according to appendix one, and used in a 
ratio of 10μL of TTC to 1mL sample. 
 
2.8.5 Fluorescein Diacetate (FDA) and Ethidium Bromide (EtBr) Double Stain 
Protocol for Live/Dead Cells 
For every sample, the concentration of FDA must be 0.025%, and EtBr 0.005%, according 
to Netuschil et al. (2014). With this double stain, actively metabolising cells will fluoresce 
green and dead cells will fluoresce red with the EtBr being able to enter dead cells.   
The one mL samples were transferred to 1.5mL eppendorf tubes and centrifuged for 20 
seconds at 8,000rmp to force the bacterial cells to the bottom of the eppendorf tube. 
700μL of supernatant was removed, and the pellet re-suspended in the remaining 
300μL. For a 300μL sample, 6μL of FDA was added and left to incubate at RT for 30 
minutes in complete absence of light. After FDA incubation, 1.5μL of EtBr was added to 
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the 300μL samples and incubated for a further 10 minutes at RT in complete absence of 
light. Then 10μL of the sample was mounted onto microscope slides and visualised 
under blue florescent light at 40x and 100x magnification. Percentage of red stained 
cells was determined visually.  
Further 100μL of each sample was taken and spread onto BHI + 199 + HS plates with a 
glass spreader. The plates were then incubated for 7 days at 37°C to determine if the 
staining produced accurate results. 
 
2.9 DNA Extraction Protocol 
DNA extraction of all the isolates was carried out in order to perform further 
downstream analysis.  
The complete contents of a culture flask containing 10mLs of M. avium culture was 
transferred to a sterile 15mL falcon tube. The falcon tube was then centrifuged at 
3,500rmp for 10 minutes at 4°C. The supernatant was carefully removed via pipette and 
the pellet re-suspended with 5mL of acetone, then incubated at RT for 10 minutes. The 
contents were then centrifuged at 3,500rpm for a further 10 minutes at 4°C, before all 
the supernatant was carefully removed. The pellet was then re-suspended in 0.5mL SDS 
Tris buffer and transferred to a bead beating tube. The samples were then beat at 6.5 
speed on (machine), following this procedure.  
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Action Amount of Time 
Bead Beater 25 seconds 
Rest 1 minute 
Bead Beater 35 seconds 
Rest 1 minute 
Bead Beater 35 seconds 
 
This step is vital in the physical lysing of the tough mycobacterium cell wall. Rests 
between bead beating steps were needed to prevent the build-up of heat from friction.  
The samples were then centrifuged at 13,000rpm for 2 minutes to remove the foam that 
had formed from bead beating. To each sample, 10μL of proteinase K was added and the 
samples were left to incubate in a thermomixer overnight at 55°C at 800rpm. 
Following overnight incubation, 0.5mL of phenol chloroform was added to the samples 
and mixed thoroughly on a rotator wheel for 5 minutes. The samples were then 
centrifuged for a further 10 minutes at 13,000rpm, before the supernatant was 
transferred into a new sterile 1.7mL eppendorf tube. To the supernatant, 100μL lysing 
SDS buffer, 100μL 5M NaOH and 80μL of CTAB buffer was added. The samples were 
then incubated at 65°C for 10 minutes at 800rpm via thermomixer. Then an equal 
volume of chloroform was added to the sample and shaken vigorously for 30 seconds. 
The samples were then centrifuged at 13,000rpm for 10 minutes. The top layer of 
supernatant was transferred to a new 1.7mL eppendorf tube and an equal volume of 
isopropyl alcohol was added. The sample was left to precipitate overnight at -20°C. 
Following the overnight incubation, the samples were centrifuged for 15 minutes at 
13,000rpm. The supernatant was removed and discarded and the remaining pellet was 
washed with 1mL of 70% EtOH. Once all the EtOH had been removed the pellet was left 
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to dry. Following drying, the pellet was re-suspended in 150μL TE buffer and analysed 
for purity on the nanodrop. 
The DNA was then stored at -4°C until required for downstream applications.  
 
2.10 Bead Beater Tube Preparation 
Capped tubes were filled with 0.1mm zirconia beads until they reached the line 
surrounding the widest part of the cone bottom. Eight 2.5mm glass beads were then 
added to the tube. Bead beater tubes were used in both DNA and RNA extraction 
protocols.    
 
2.11 Restriction Enzyme Digest Protocol 
Into a 1.7mL eppendorf tube, 1μL of sample DNA (with a concentration of 200-
400ng/μL), 2μL of 10X Buffer 4, 1μL of MB01 restriction enzyme and 16μL of sterile 
mQH2O was pipetted. The sample was then incubated at 37°C at 700rpm for 12 hours. 
Following this the temperature was then increased to 65°C for 10 minutes to deactivate 
the MB01 enzyme. The digested DNA was then stored at 4°C until required for 
downstream applications.  
 
2.12.1 RNA Preparation 
For each RNA sample, four 1.5mL cultures of isolate 6 were cultured and treated before 
being used for RNA extraction. A total of 9mL of culture was needed to ensure enough 
RNA was isolated for downstream applications.  
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Into a sterile falcon tube, 20mL BHI+ 199 media was added. One mL of working culture 
was used to inoculate the 20mL media. The inoculated media was then distributed into 
1.5mL aliquots into yellow screw top tubes. For the biofilm RNA samples, a glass 
coverslip was added to the bottom of the tube to promote biofilm formation over 
planktonic growth. These tubes were then incubated for three days at 37°C to promote 
growth. Into the tubes that would serve as the aspirin RNA isolates, 54μL of 100mg/mL 
aspirin was added. All the samples were then incubated over night at 37°C and the RNA 
was harvested the following morning via section 2.12.2.  
 
2.12.2 RNA Extraction Protocol 
The supernatant from the biofilm, and biofilm treated with aspirin samples was carefully 
removed and discarded. To the aspirin and biofilm samples, 0.5mL of 5M GITC was 
added to aid in the preservation of RNA throughout the extraction process. Five to ten 
2.5mm glass beads were then added to aid in the breaking down of the biofilm, and the 
samples were vortexed for 20-30 seconds. To remove the build-up of foam the samples 
were then centrifuged at 2,500rpm for 5 minutes at 4°C. 
The planktonic samples were then pipetted into 1.7mL eppendorf tubes and were 
centrifuged for 1 minute at 13,200rpm. Following this, the supernatant was removed 
and 0.5mL of GITC was added to the tube, then the pellet was re-suspended in the GITC.  
 Bead beater tubes were then prepared according to previously described protocol 
(section 2.10). All samples (aspirin treated biofilm, biofilm and planktonic cells) were 
then added to bead beater tubes and then beaten at 6.5 speed, following this 
procedure. 
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Action Amount of Time 
Bead Beater 30 seconds 
Rest 1 minute 
Bead Beater 35 seconds 
Rest 1 minute 
Bead Beater 40 seconds 
 
The samples were then immediately put on ice and centrifuged at 13,200rpm for 1 
minute at 4°C to remove the build-up of foam.  
The correlating samples were all pooled into three 1.5mL eppendorf tubes, to give three 
1mL sample for aspirin treated biofilm, a further three 1mL sample for biofilm, and 
repeated for planktonic cells.  
To each tube containing 1mL sample, 100μL of 2M NaAc (at pH 4) was added. This was 
to lower the pH and maintain DNA at the interface and not in the supernatant. 
Furthermore, to each 1mL sample, 750μL of RNA grade water saturated phenol (at pH 
4.3) was added. All the samples were then violently shaken for 20 seconds, before being 
placed on the rotator wheel for 10 minutes. Following their rotation, 200μL of bromo-
chloropropopane was added to each sample. The samples were then violently mixed for 
a further 20 seconds, and placed back on the rotor wheel for 5 minutes. Afterwards, the 
samples were then centrifuged for 10 minutes at 12,200rpm at 4°C. 
The top layer of supernatant was then transferred to 1.7mL eppendorf tubes using a fine 
sterile pipette tip. 0.1mL of bromo-chloropropopane was added to each sample and 
violently mixed for a further 20 seconds to ensure the proteins within the sample were 
being degraded. The samples were then centrifuged for 9 minutes at 12,200rpm at 4°C. 
The supernatant was removed and an equal volume of isopropanol was added. The total 
RNA was left to precipitate overnight at -20°C. 
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After precipitation, the total RNA was washed with 70% EtOH, centrifuged to remove all 
remaining EtOH. Then the RNA pellet was re-suspended in TE Buffer and stored at -80°C.  
 
2.12.3 Transcriptome Analysis  
RNA samples were then sent to the Beijing Genomics Institute 
(http://www.genomics.cn/en/index) for further transcriptome processing, quality 
control and analysis.   
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Chapter Three 
3. Results 
3.1 PCR Results 
 
3.1.1 DNA Quality  
The following results were recorded on Thermo Fischer Scientific ™ Nanodrop 2000 ™ 
Spectrophotometer.  
Table 3. DNA quality and concentration after DNA extraction was performed on isolates. 
Isolate 260/280 230/260 Concentration ng/μL 
1 1.93 1.82 57.2 
2 1.99 2.02 649.2 
3 2.02 0.76 33.8 
4 1.81 0.49 6.6 
5 2.01 2.10 450.4 
6 2.04 2.11 518.2 
7 2.02 2.19 651.4 
8 1.85 2.03 300.5 
9 1.89 2.01 457.3 
10 1.99 2.06 522.7 
11 2.05 1.99 316.4 
A 1.83 1.92 583.3 
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3.1.2.1 PCR Identification 
PCR with MAI forward and reverse primers, showed that all isolates, except 3 and 4 
were M. avium. This was also confirmed by Waikato Hospital. It is likely that isolates 3 
and 4 are other Mycobacterium species found in MAC infections.  
 
Figure 5. Gel electrophoresis photo showing the band size produced from performing a PCR on the 
extracted DNA with MAI primers. The expected band size produced, 146bp, can be seen in this picture. The 
isolate numbers are shown across the top, corresponding with their band size, as well as N (negative 
control), showing no contamination. 
 
Figure 6. Gel electrophoresis photo showing the band size produced from performing a PCR on the extracted 
DNA with MAI primers. This PCR was repeated 6 months after the first identification PCR. The expected band 
size produced, 146bp, can be seen in this picture. The isolate numbers are shown across the top, 
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corresponding with their band, as well as N (negative control), showing no contamination in the PCR reaction 
mix. 
3.1.2.2 PCR Subspecies Identification 
Observed differences in isolate phenotype, in both broth media and biofilm formation 
on glass coverslips, was confirmed by SAUTYPE PCR and DT1 and IS1311 primer sets.  
3.1.2.2.1 SAUTYPE PCR 
SAUTYPE PCR showed that all isolates differed in their genomic composition, with 
exception to isolates 6 and 11. No two isolates had the same restriction digest 
fragmentation pattern and SAUTYPE PCR results as seen in figure 7 below.  
 
Figure 7.  Gel image showing PCR with STG primers and MBO1 restricted DNA of all isolates. 
 4                3              2            1            A             N                    100bp L 
 11           10            8            7               6             5                    100bp L 
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3.1.2.2.2 DT1 and IS1311 Identification 
PCR samples positive for DT1 should show fragments at ~269bp and PCR samples 
positive for IS1311 should show fragments ~608bp in size.  
As seen in figure 8, isolate 1 and 8 shared similar PCR fragmentation, with a fragment 
size ~269bp and a very faint fragment ~608bp. Isolates 3 and 4 shared similar PCR 
fragments, with both band sizes at ~269bp, ~608bp and ~800bp. Isolates 5, 6 and 11 
showed similar PCR fragment amplification. All other isolates showed a single band at 
~608bp. 
Therefore, isolates 2, 5, 6, 7, 10, 11 and A are either M. avium subsp. paratuberculosis or 
M. avium subsp. hominissuis. Isolates 1 and 8 are M. avium subsp. avium. Isolate 9 
remains unknown. Isolates 3 and 4 are confirmed as not M. avium.  
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Figure 8. Gel image showing subtype identification PCR carried out with DT1 and IS1311 primer sets. 
 
3.2 Planktonic Cell Experiments 
Experiments were conducted on planktonic M. avium cell populations to determine 
their MICs in broth, using the MTT analysis method. 
Clarithromycin was most effective at inhibiting planktonic M. avium (absorbance 
dropping from 0.868 in the control to 0.529 at a 10μg/mL concentration). Ciprofloxacin 
also showed a decreasing trend (absorbance dropping from 0.687 in the control to 0.569 
at a 20μg/mL concentration). Amikacin, cefoxitin and doxycycline, all showed an 
increase in cell metabolism at a 2.5μg/mL concentration, and no significant cell 
inhibition at higher drug concentrations (figure 9). 
        3         2         1        A1       A2       A3        A4                      100bp L 
                   11      10        8         7           6         5          4             100bp L 
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Figure 9. MTT ODs absorbance values for M. avium planktonic cells treated with varying concentrations of 
antibiotics (0μg/mL to 20μg/mL). 
 
The experiment was repeated, however 25μg/mL of doxycycline was also added. 
Compared to the control (absorbance = 2.289), OD increased with the addition of 
25μg/mL of doxycycline (absorbance = 2.386). Again, clarithromycin and cefoxitin alone 
were the most effective antibiotics against M. avium isolate 6. Amoxicillin at 2.5μg/mL 
combined with 25μg/mL of doxycycline showed synergy, ciprofloxacin at 10μg/mL with 
25μg/mL doxycycline and clarithromycin at all concentrations combined with 25μg/mL 
doxycycline showed significant synergy, compared to their absorbance values without 
25μg/mL doxycycline (figure 10). However, 5μg/mL of cefoxitin alone had the most 
0
0.5
1
1.5
2
2.5
0 2.5 5 10 20
A
b
so
rb
an
ce
 a
t 
5
7
0
n
m
Antibiotic Concentration (μg/mL)
Planktonic Cells: Absorbance vs. 
Increasing Antibiotic Concentration
Amakacin
Amoxicillin
Cefoxitin
Ciprofloxican
Clarithromycin
Doxycycline
Rifampicin
52 
 
effect on inhibiting M. avium questioning the usefulness of doxycycline being used as a 
synergistic antibiotic in treatment of M. avium infection.   
 
Figure 10. MTT ODs of M. avium isolate 6 planktonic cells, grown overnight, treated with varying 
concentrations of single antibiotics, and antibiotics combined with 25μg/mL of doxycycline. 
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All isolates were found to be resistant to concentrations of 15μg/mL, with no antibiotics 
achieving complete sterilization. Rifinah ™ (rifampicin + isoniazid), rifampicin and 
doxycycline consistently increased planktonic cell populations across all isolates, with 
absorbance values that exceeded the control (figure 11). Aspirin combined with 
ibuprofen (both at 3.6mg/mL concentrations) consistently reduced planktonic cell 
metabolism across all isolates, proving more effective than clarithromycin which was the 
most effective out of the antibiotics.  
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Aspirin at concentrations of 3.6mg/mL had substantial inhibitory effects across all 
isolates (figure 12). This inhibitory effect improved when aspirin (3.6mg/mL) was 
combined with 15μg/mL clarithromycin. N-acetyl-L-cysteine had weaker effects, even 
promoting growth in isolate 1 compared to the control.  
 
Figure 12. Corresponding MTT ODs of M. avium planktonic cells from three isolates treated with antibiotics 
and potential biofilm dispersing agents. 
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Furthermore aspirin (at a concentration of 3.6mg/mL) showed synergistic effects on 
planktonic M. avium cells when combined with 15μg/mL clarithromycin (figure 13). The 
average absorbance value across all confirmed M. avium isolates dropped from 1.34 in 
the untreated control to 0.6 in the aspirin and clarithromycin treated isolates. Both 
aspirin (3.6mg/mL) and ibuprofen (3.6mg/mL) had more effect on planktonic M. avium 
isolates than 15μg/mL clarithromycin. Unlike aspirin, the addition of 3.6mg/mL 
ibuprofen did not increase the effectiveness of aspirin combined with clarithromycin 
(figure 13).  
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Figure 13. MTT average ODs of M. avium planktonic cells taken from four day old mature biofilms and 
treated with antibiotics and potential biofilm dispersing agents. 
 
3.2.1 Aspirin Effectiveness Against Planktonic Mycobacterium avium Cells 
A dilution series was made and MTT analysis performed on the planktonic cells. Aspirin 
effectivity against planktonic M. avium populations decreased with decreasing 
concentration (table 4).  
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Table 4. MTT ODs on M. avium isolate 6 planktonic cells, grown overnight, treated with varying 
concentrations of aspirin.  
Dilution factor Aspirin Concentration OD absorbance at 570nm 
Control 0mg/mL 0.706 
1:2 1.8mg/mL 0.125 
1:4 0.9mg/mL 0.281 
1:8 0.45mg/mL 0.457 
1:16 0.225mg/mL 0.560 
1:32 0.1125mg/mL 0.634 
 
This experiment was then repeated with a 1.8mg/mL aspirin concentration and different 
antibiotics. No significant synergy was found between aspirin and antibiotics (table 5). 
However, aspirin had a tenfold decrease in planktonic cell population compared to the 
control. 
Table 5. MTT ODs on M. avium isolate 6 planktonic cells, grown overnight, treated with 1.8mg/mL aspirin 
and 5μg/mL of antibiotics that previously showed effect on M. avium planktonic cells. 
Conditions OD absorbance at 570nm 
Control (0mg/mL) 1.727 
Aspirin (1.8mg/mL) 0.174 
Aspirin (1.8mg/mL) +5μg/mL Clarithromycin 0.354 
Aspirin (1.8mg/mL) + 2.5μg/mL Amikacin 0.184 
Aspirin (1.8mg/mL) + 5μg/mL Cefoxitin 0.228 
Aspirin (1.8mg/mL) + 5μg/mL Ciprofloxacin  0.196 
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The experiment was repeated on four day old planktonic cell populations using 
decreasing aspirin concentrations and combined antibiotic therapies (figure 14). Aspirin 
again showed a dependency on concentration for effective inhibition of M. avium 
growth. A minimal dosage of aspirin (0.45mg/mL) combined with 5µg/mL of 
clarithromycin showed similar levels of activity against planktonic cells as 1.8mg/mL 
concentration of aspirin alone. Aspirin at 0.9mg/mL combined with 5µg/mL of 
clarithromycin and 5µg/mL of ciprofloxacin also showed the same level of inhibition to 
M. avium planktonic cell metabolism (figure 14).      
 
 
Figure 14. MTT ODs from M. avium planktonic cells treated with increasing concentrations of aspirin, and a 
combination of antibiotics.  
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3.2.2 Antibiotic and Biofilm Dispersal Agents MICs With TTC Indicator on 
Mycobacterium avium Planktonic Cells 
TTC was then used to determine relative MICs of planktonic cells. MIC was determined 
by 0% red colouration in the cell populations, indicating complete sterilization.  
Amikacin, amoxicillin, ciprofloxacin, clarithromycin and moxifloxacin all had complete 
sterilization at concentrations of 128µg/mL, while no MIC could be determined for 
cefoxitin, doxycycline, ethambutol, rifampicin and Rifinah ™. Aspirin had complete 
eradication at 4mg/mL, while ibuprofen sterilized at 1mg/mL (table 6).  
Table 6. TTC Colorimetric deduced MICs of M. avium. 
Treatment Concentration of Treatment 
Antibiotic 
1µg 
/mL  
2µg 
/mL  
4µg 
/mL  
8µg 
/mL  
16µg/
mL  
32µg
/mL  
64µg
/mL  
128µg
/mL  
Amikacin Red Red Red Red Red Red Red Clear 
Amoxicillin Red Red Red Red Red Red Red Clear 
Cefoxitin Red Red Red Red Red Red Red Red 
Ciprofloxacin Red Red Red Red Red Red Red Clear 
Clarithromycin Red Red Red Red Red Red Red Clear 
Doxycycline Red Red Red Red Red Red Red Red 
Ethambutol Red Red Red Red Red Red Red Red 
Moxifloxacin Red Red Red Red Red Red Red Clear 
Rifampicin Red Red Red Red Red Red Red Red 
Rifinah ™  Red Red Red Red Red Red Red Red 
         
         
Biofilm 
Disruptor 
0.075
mg/mL 
0.125
mg/
mL 
0.25 
mg/ 
mL 
0.5mg
/mL 
1mg/
mL 
2mg/
mL 
4mg/
mL 
8mg/
mL 
Aspirin Red Red Red Red Red Red Clear Clear 
Ibuprofen Red Red Red Red Clear Clear Clear Clear 
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3.2.3 FDA and EtBr Staining 
Although no results produced a completely sterilized sample, across multiple isolates 
planktonic cells treated with 3.6mg/mL aspirin showed the greatest percentage of red 
fluorescing cells (88.9% average), thus cell death. For isolates 9 and 10, all samples 
showed growth on plates, except for those treated with 3.6mg/mL aspirin.  
 
Again, isolate differed in susceptibility to both aspirin and ibuprofen combined with 
antibiotics. The average percentage of dead cells from the ten confirmed M. avium 
isolates showed that 3.6mg/mL of aspirin was most effective against planktonic cells 
(figure 15). However, aspirin combined with all other antibiotics produced 65% and 
higher dead M. avium planktonic cells within the sample.  
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Figure 15. Average percentage of planktonic cell death on 10 M. avium isolates treated with 3.6mg/mL 
aspirin in combination with 16ug/mL concentration of antibiotics. The percentage of dead cells indicates the 
amount of cells fluorescing red under blue light, after FDA/EtBr staining.  
Ibuprofen at 1mg/mL did not show as significant percentages of dead cells as 3.6mg/mL 
aspirin. Ibuprofen combined with ethambutol and ciprofloxacin showed the greatest 
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increase in red stained cells, while both rifampicin and Rifinah™ had the least effect 
(figure 16). 
 
Figure 16. Average percentage of planktonic cell death on 10 M. avium isolates treated with 1mg/mL 
ibuprofen in combination with 16ug/mL concentration of antibiotics. The percentage of dead cells indicates 
the amount of cells fluorescing red under blue light, after FDA/EtBr staining. 
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3.3 Biofilm Formation 
Experiments were conducted on mature biofilm populations of M. avium to ascertain 
the MICs of M. avium in biofilm phenotype.   
3.3.1 Optimal Biofilm Growth Media  
Middlebrook 7H9 media gave the best MTT OD absorbance readings at 570nm (1.036), 
suggesting that M. avium is best cultured in this media.  
Table 7. Comparison of different growth media, and the optical density of resulting MTT analysis. Brain 
Heart Infusion combined with Middlebrook 7H9 media gave the best growth results. 
Growth Media  OD at 570nm 
Middlebrook 7H9 + 3% Glycerol 0.008 
Middlebrook 7H9 + Tween80 0.001 
199 Media + 3% Glycerol 0.492 
BHI Media + Middlebrook 7H9 1.036 
199 Media + 3% Glycerol + Nutrient Broth  0.309 
 
 
Figure 17. MTT analysis of different growth media. From left to right; Middlebrook 7H9 + 3% Glycerol; 
Middlebrook 7H9 + Tween80; 199 Media + 3% Glycerol; BHI Media + Middlebrook 7H9; 199 Media + 3% 
Glycerol + Nutrient Broth. 
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However, in contrast to the MTT results, under auramine-O acid alcohol methylene blue 
counter stain, the most efficient biofilm producing media was Middlebrook 7H9 with 
Tween80 (figure 18).  
 
  
Figure 18. Microscope images of auramine-O, acid alcohol methylene blue counter stained biofilms, 
performed on isolate 6 under various media conditions after being grown overnight. A) Biofilm grown in 199 
Media + 3% glycerol + Nutrient Broth media. B) Biofilm grown in Middlebrook 7H9 media + 3% glycerol. C) 
Biofilm grown in Middlebrook 7H9 media + Tween80. D) Biofilm grown in Brain Heart Infusion media + 
Middlebrook 7H9 media. 
 
a) b) 
c) d) 
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3.3.2 Glass Versus Polystyrene Biofilm Growth Promotion 
In comparison between the optimal surfaces for biofilm development crystal violet 
staining showed that the glass beads had increased biofilm growth over polystyrene 
beads.  
Table 8. Crystal Violet Staining OD absorbance readings at 570nm comparing glass and polystyrene beads. 
Surface Type OD at 570nm 
Polystyrene Bead 0.035 
Polystyrene Bead Repeat 0.115 
Glass Bead 0.227 
Glass Bead Repeat 0.180 
 
3.3.3 Biofilm Phenotype Observations 
Definite phenotypes of biofilm were observed between isolates. Isolates 6 and A1 
(shown as A in the figure below) formed iris-like coverings across the whole glass cover 
slip, whereas isolates 8 and 11 clumped in the middle of the coverslip. Furthermore, 
isolates A1, A2 and A3 (both strains from the same patient) formed iris-like coverings 
across the glass coverslip as well as having clumps of biofilm accumulating across the 
coverslip.  
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Figure 19. Photograph showing the different biofilm growth patterns of M. avium isolates across glass 
coverslips in BHI + 199 media. The isolates read left to right, 6, 8, 11, A1 (marked on plate as A), A2, (marked 
on the plate as C), A3 (marked on the plate as D). 
The phenotype differences of isolates were observed by auramine-O acid alcohol 
methylene blue staining. Isolate 6 was the most efficient biofilm producer (figure 20).  
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Figure 20. Six images showing isolate 6 biofilm under blue light after auramine-O, methylene blue staining. 
40x magnification. Note prolific biofilm formation. 
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Figure 21. Isolate 8 under blue light after auramine-O, methylene blue staining. 40x magnification. 
 
Figure 22. Isolate 11 under blue light after auramine-O, methylene blue staining. 100x magnification. 
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Figure 23. Isolate A1 under blue light after auramine-O, methylene blue staining. 40x magnification.
 
Figure 24. Isolate A2 under blue light after auramine-O, methylene blue staining. 40x magnification 
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Isolate differences were also determined by treating the isolates with 8μg/mL of 
cefoxitin. Isolate 6 proved the most susceptible to cefoxitin. 
Table 9. Resulting ODs after MTT analysis on planktonic cells treated with 8μg/mL of cefoxitin. Isolates A1, 
A2 and A3 were all taken from the same patient at different time points in the infection. 
Isolate Planktonic Cells OD 
6 0.054 
8 0.089 
11 0.158 
A1 0.121 
A2 0.102 
A3 0.140 
 
3.4 Antibiotic Biofilm Experiments 
Biofilms were cultivated for four days at 37°C. Antibiotics were then added to mature 
biofilms and left to incubate overnight. Biofilms were then analysed the following day 
via the MTT protocol as outlined in the methods.  
3.4.1 Biofilm Cells Increased Resistance to Cefoxitin 
Initial results revealed the enhanced growth of M. avium populations after being treated 
with cefoxitin. This can be seen in table 10, where the ODs of planktonic cells were all 
lower, or of almost equal value as the untreated biofilm. However, the ODs between the 
control biofilm and the treated biofilm increased greatly across all isolates, except 
isolate 8.  
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Table 10. Resulting ODs after MTT analysis on biofilm cells. Biofilm cells were treated with 8μg/mL of 
cefoxitin. Control biofilm cells were not treated with cefoxitin. Isolates A1, A2 and A3 were all taken from 
the same patient at different time points in the infection. 
Isolate Treated Biofilm Cells OD Control Biofilm Cells OD 
6 0.578 0.201 
8 0.106 0.105 
11 0.427 0.176 
A1 0.427 0.131 
A2 0.340 0.142 
A3 0.518 0.136 
   
 
 
3.4.2 Increasing Antibiotic Concentration Against Mature Biofilms 
Amoxicillin, ciprofloxacin and clarithromycin were most effective against mature 
biofilms (as seen in figure 25), however no antibiotic was able to completely eradicate 
the pre-existing biofilm. There was no significant reduction in biofilm formation with 
increasing antibiotic concentration (figure 25).  
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Figure 25. MTT ODs on seven day old mature M. avium isolate 7 biofilms treated with varying 
concentrations of antibiotics. Raw MTT results were diluted 1:2 to provide accurate readings, and therefore, 
these absorbance values have been doubled to reflect this. 
Antibiotic resistance variation was further explored between isolate biofilms. Rifampicin 
was chosen because of its apparent weaker antibiotic effect on M. avium biofilms and 
clarithromycin was chosen because of its strongest antibiotic effect on the biofilms. 
Across all isolates, increasing antibiotic concentration did not significantly decrease cell 
metabolism within a biofilm (figure 26 and figure 27). 
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Figure 26. MTT ODs on five M. avium seven day old mature biofilms, treated with varying concentrations of 
rifampicin. Raw MTT results were diluted 1:2 to provide accurate readings, and therefore these absorbance 
values have been doubled to reflect this. 
 
Figure 27. MTT ODs on five M. avium isolates, seven days old mature biofilms, treated with varying 
concentrations of clarithromycin. Raw MTT results were diluted 1:2 to provide accurate readings, and 
therefore these absorbance values have been doubled to reflect this. 
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3.4.3 Antibiotic Synergy against Mature Biofilm  
Isolate 1 through to 6 were tested for potential antibiotic synergy on M. avium biofilms 
(figure 28). Biofilms of non- M. avium isolates (isolates 3 and 4) were particularly 
susceptible to clarithromycin (2.5μg/mL) combined with ciprofloxacin (2.5μg/mL), as 
well as clarithromycin (2.5μg/mL) combined with doxycycline (2.5μg/mL). M. avium 
isolates ranged in their susceptibility to combination antibiotic therapy.  
 
However, the average results from all four isolates showed that clarithromycin alone 
was the most effective at inhibiting biofilm metabolism (figure 29).  
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Figure 28. Comparison between MTT ODs on six, week old M. avium biofilms, after being treated with seven 
different antibiotics at 2.5μg/mL concentrations. Raw MTT results were diluted 1:2 to provide accurate 
readings, and therefore these absorbance values have been doubled to reflect this. 
0
1
2
3
4
5
6
1 2 3 4 5 6
A
b
so
b
an
ce
 a
t 
5
7
0
n
m
Isolate 
Biofilm: Isolate Differences in Response to 
Antibiotic Synergy
Control
2.5μg/mL Clarithromycin
2.5μg/mL Clarithromycin+ 2.5μg/mL Amakacin
2.5μg/mL Clarithromycin + 2.5μg/mL Amoxicillin 
2.5μg/mL Clarithromycin + 2.5μg/mL Cefoxitin
2.5μg/mL Clarithromycin + 2.5μg/mL Ciprofloxacin
2.5μg/mL Clarithromycin+ 2.5μg/mL Doxycycline 
2.5μg/mL Clarithromycin+ 2.5μg/mL Rifampicin
79 
 
 
Figure 29. Average MTT ODs of six, week old M. avium biofilms, after being treated with seven different 
antibiotics at 2.5mg/mL concentrations. Raw MTT results were diluted 1:2 to provide accurate readings, and 
therefore, these absorbance values have been doubled to reflect this.  
The concentration of antibiotics were increased to 15μg/mL and both aspirin and 
ibuprofen at 3.6mg/mL were used against M. avium mature biofilms across all isolates. 
The average absorbance of all confirmed M. avium isolates showed that 15μg/mL 
clarithromycin was most effective antibiotic against M. avium biofilms agreeing with our 
planktonic results (figures 9, 10 and 11). However, the absorbance values were all 
significantly higher than the planktonic populations (figure 30). Doxycycline (at 
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15μg/mL) was the most ineffective antibiotic tested. No MICs for M. avium isolates were 
able to be determined due to the high resistance of all M. avium biofilms.      
 
Figure 30. Average MTT ODs of 10 three day old mature M. avium biofilms treated with varying antibiotics 
at 15μg/mL. Raw MTT results for untreated control samples were diluted 1:2 to provide accurate readings, 
and therefore these absorbance values have been doubled to reflect this. 
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 3.5 Biofilm Dispersing Agents 
 
Three day old biofilms were treated with three biofilm dispersing agents, L-arginine (at 
4mg/mL), 2,4-dinitrophenol (DNP) (at 10μg/mL) and Lipitor ™ (at 10μg/mL),  in 
conjunction with three antibiotics at a concentrations between 2.5μg/mL and 5μg/mL 
(figure 31). The treated biofilms and planktonic cells were incubated over 48 hours, 
before an MTT analysis was carried out and the absorbance was measured at 570nm. No 
significant decrease of M. avium biofilms were observed. L-arginine was found to greatly 
increase biofilm formation even with the presence of antibiotics. DNP (at 10μg/mL) 
combined with 5μg/mL clarithromycin and 5μg/mL ciprofloxacin had the most effect on 
M. avium biofilms, however, this was not significant.  
 
Figure 31. Average MTT ODs of 6, three day old, mature M. avium biofilms treated with varying antibiotics 
at 2.5-5μg/mL concentrations and potential biofilm dispersing agents. 
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This protocol was repeated with methylglyoxal (MGO) (at 10μg/mL), mannitol (at 
40mM) and active manuka honey (at 0.2%) Again, no potential biofilm distributors 
significantly increased the effect of the antibiotics against mature biofilms (table 11). 
Table 11. MTT ODs at 570nm, on four day old mature M. avium isolate 6 biofilms, treated with potential 
biofilm dispersing agents. Raw MTT results were diluted 1:2 to provide accurate readings, and therefore 
these absorbance values have been doubled to reflect this. Samples denoted with an asterisk show samples 
that had poor biofilm growth before treatment. 
Treatment and 
Concentration Control 
MGO 
(10μg/mL) 
Mannitol 
(40mM) 
Lipitor 
(10μg/mL) 
DNP 
(10μg/mL) 
Active 
Manuka 
(0.2%) 
0μg/mL 2.672 2.32 1.876 1.669 1.379 1.82 
5μg/mL Clarithromycin 1.568 2.153 1.284 1.428 1.349 1.273 
5μg/mL Clarithromycin + 
5μg/mL Cefoxitin 1.699 2.053 1.053 1.145 1.086 1.134 
5μg/mL Clarithromycin + 
5μg/mL Ciprofloxacin 0.514* 0.798* 1.626 1.58 1.294 1.243 
 
Aspirin (at a 4mg/mL concentration) combined with EDTA (at a 8mg/mL concentration) 
resulted in complete eradication of the M. avium biofilm as well as complete 
sterilization as seen in table 12 below (absorbance at 570nm =0.102). 
Table 12. MTT ODs at 570nm, on four day old mature M. avium biofilms, treated with potential biofilm 
dispersing agents. Samples denoted with an asterisk show samples that had poor biofilm growth before 
treatment. 
 Control 
MGO 
(10μg/mL) 
Mannitol 
(40mM) 
Lipitor 
(10μg/
mL) 
DNP 
(10μg/mL) 
Active 
Manuka 
(0.2%) 
Aspirin 
(4mg/mL) 
+ EDTA 
(8mg/mL) 
Absorbance at 
570nm 2.327 1.62 1.615 0.695* 2.044 1.97 0.102 
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3.6 Aspirin as a Potential Mycobacterium avium Biofilm Distributor 
The drastic effects of aspirin on M. avium planktonic cells was not seen against all M. 
avium mature biofilm isolates (figure 32). Again, the isolates all showed a wide variety of 
susceptibility to antibiotic treatment. In contrast to all other isolates tested, isolate 1 
was more inhibited by 5μg/mL Clarithromycin than aspirin (at a 1.8mg/mL 
concentration).   
 
Figure 32. MTT ODs of six, week old M. avium biofilms, comparing aspirin at 1.8mg/mL concentrations to 
5μg/mL clarithromycin concentrations, and showing their effectiveness combined. Raw MTT results were 
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diluted 1:2 to provide accurate readings, and therefore these absorbance values have been doubled to 
reflect this. 
The averages from all ten confirmed M. avium isolates showed a decrease of 
absorbance value with increasing aspirin concentration (figure 33).  Half of the 
maximum therapeutic concentration of aspirin (1.8mg/mL) achieved better cell 
inhibition than 5μg/mL clarithromycin. A concentration of 1.8mg/mL aspirin combined 
with 5μg/mL clarithromycin was more effective than the maximum therapeutic 
concentration (3.6mg/mL) of aspirin alone. However, 3.6mg/mL aspirin combined with 
5μg/mL clarithromycin was the most effective, with average absorbance dropping from 
2.681 (untreated control) to 1.307 (figure 33).  
 
Figure 33. Average MTT ODs from 10, mature M. avium biofilms, comparing aspirin at 1.8mg/mL and 
3.6mg/mL to 5μg/mL clarithromycin, and showing their effectiveness combined. Raw MTT results were 
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diluted 1:2 to provide accurate readings, and therefore, these absorbance values have been doubled to 
reflect this. 
The concentration of antibiotics used was increased to 15μg/mL, to try and replicate 
earlier kill results of aspirin. Ibuprofen was also investigated as a potential M. avium 
biofilm dispersing agent, and was shown to be the more effective against M. avium 
biofilms at the same concentration than aspirin (figure 34). Aspirin combined with 
ibuprofen (both at a concentration of 3.6mg/mL) were the most effective against 
mature biofilms (absorbance decreasing from 2.769, in the control, to 0.937). The 
addition of 15μg/mL did not improve the effectiveness of aspirin with ibuprofen. 
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Figure 34. Average MTT ODs of three to four day old mature M. avium biofilms treated with 3.6mg/mL 
aspirin and/or 3.6mg/mL ibuprofen with/without 15μg/mL antibiotics. Raw MTT results were diluted 1:2 in 
order to be accurately read on the spectrophotometer, however, data displayed has been doubled to reflect 
this. 
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More experiments into potential biofilm distributors, such as N-acetyl-L-cysteine and 
ibuprofen, were conducted using isolates 1, 6 and 11 as they offered the most diverse 
range of biofilm phenotype and drug resistance. Against isolate 1 a concentration of 
3.6mg/mL aspirin was the most effective (absorbance value of 0.857) and was not 
enhanced by the addition of 15μg/mL clarithromycin or 4mg/mg N-acetyl-L-cysteine. 
However, both isolate 8 and 11 mature biofilms showed susceptibility to aspirin 
(3.6mg/mL) in combination with N-acetyl-L-cysteine ( at a concentration of 4mg/mL). 
This susceptibility increased further when 15μg/mL of clarithromycin was added (figure 
35). 
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Figure 35. Four day old mature M. avium biofilms treated with antibiotics and potential biofilm dispersing 
agents. 
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3.7 Longevity of Aspirin on Mycobacterium avium 
To analyse whether the effect seen with aspirin on M. avium was bactericidal or 
bacteriostatic an experiment was carried out into the longevity of aspirin. Aspirin 
remained effective over a 5 day period as seen in table 13. 
Table 13. Growth of untreated isolate 6 on BHI + 199 agar plates in comparison to aspirin treated isolate 6. 
Day Growth on plates spread with 
aspirin treated isolate 
Growth on control plates spread 
with untreated isolate 
1 No Yes 
2 No Yes 
3 No Yes 
4 No Yes 
5 No Yes 
 
 
3.8 Acidity of Aspirin 
The acidity of the stock 100mg/mL aspirin solution was measured, to determine if an 
acidic environment was causing the decrease in biofilm growth via lower absorbance 
values. Aspirin did cause a decrease in pH of the growth media (table 14). Therefore 
100mg/mL aspirin stock was made in EtOH and adjusted with NaOH to pH 6.5. A 1/100 
1M ACES Buffer was added to the BHI + 199 media to resist any pH change with the 
addition of aspirin.  
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Table 14. pH of BHI + 199 media and aspirin. 
Solution pH 
BHI + 199 media  6.5 
BHI + 199 media + 4μL aspirin of 100mg/mL stock aspirin 
solution 
6.65 
BHI + 199 media + 40μL of 100mg/mL stock aspirin solution 5.18 
BHI + 199 media + 1/100 1M ACES Buffer + 40μL of 100mg/mL 
stock aspirin solution 
6.53 
3.9 SEM Images 
Isolate 6 was chosen for SEM imaging, as it had previously shown to be an efficient 
biofilm producer under auramine-o, methylene blue staining (figure 20). 
The untreated control sample showed aggregation of cells, and little cellular damage, as 
seen in figure 36. MTT analysis of replicate samples showed the untreated control had 
an absorbance value of 2.727 at 570nm.  
 
Figure 36. SEM image showing untreated M. avium bacterial cells, displaying normal biofilm growth. MTT 
OD reading of 2.727 at 570nm 
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All samples had sufficient biofilm growth, and pore channels could clearly be seen, as 
shown below in figure 37. 
 
Figure 37. Untreated control M. avium biofilm, showing dynamic three-dimensional shape with pore 
channel. MTT OD reading of 2.727 at 570nm. 
Comparison of the control (figure 36) to the images below (figure 38), the addition of 
4mg/mL aspirin shows cellular damage to the bacterial cells. The cell walls appear flaky 
and wrinkled with the actual cells seeming distorted and dimpled in comparison to the 
control (as seen below) .This was also replicated in MTT analysis, where the addition of 
aspirin decreased absorbance value to 1.045 at 570nm 
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Figure 38. M. avium mature biofilm treated with 4mg/mL aspirin. MTT OD reading of 1.045 at 570nm. 
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Treatment with 5μg/mL clarithromycin, cefoxitin and ciprofloxacin showed apparent 
wrinkling and cracking of the cellular surface. Samples treated with 5μg/mL 
clarithromycin showed increased aggregation of cells (figure 39).  
 
Figure 39. M. avium mature biofilm treated with 5μg/mL clarithromycin. MTT OD reading of 1.659 at 
570nm.  
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Figure 40. Three SEM images showing M. avium mature biofilm treated with 5μg/mL cefoxitin. Note the 
formation of “fibres” between the cells. MTT OD reading of 1.944 at 570nm. 
 
96 
 
 
Figure 41. Two SEM images showing M. avium mature biofilm treated with 5μg/mL ciprofloxacin. Note the 
aggregation between the cells and development of a coating over the cells. MTT OD reading of 2.219 at 
570nm. 
The treatment of M. avium biofilms with DMSO shows the same cell aggregation was 
seen as samples treated with 5μg/mL ciprofloxacin (figures 41 and 42). This aggregation 
increased when antibiotics were also added to the sample (figures 43, 44 and 45). DMSO 
did not significantly affect M. avium biofilm, nor have a synergistic effect with 
antibiotics.   
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Figure 42. M. avium mature biofilm treated with 40μL/mL DMSO. Note the aggregation between the cells 
and slight development of a coating over the cells. MTT OD reading of 2.428 at 570nm. 
 
Figure 43. M. avium mature biofilm treated with 40μL/mL DMSO and 5μg/mL clarithromycin. Note the 
increased aggregation between the cells and development of a coating over the cells. MTT OD reading of 
2.127 at 570nm. 
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Figure 44. M. avium mature biofilm treated with 40μL/mL DMSO and 5μg/mL cefoxitin. Note the increased 
aggregation between the cells and development of a coating over the cells. MTT OD reading of 2.002 at 
570nm. 
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Figure 45. M. avium mature biofilm treated with 40μL/mL DMSO and 5μg/mL ciprofloxacin. Note the 
increased aggregation between the cells and development of a coating over the cells. MTT OD reading of 
2.525 at 570nm. 
In contrast to the samples treated with antibiotics only (figure 39, 40 and 41), when 
4mg/mL aspirin was also added to the 5μg/mL clarithromycin, reduced cell aggregation 
and increased cellular damage was observed to a greater extent than with 4mg/mL 
aspirin alone. The damaged cells were extremely distorted in shape, in comparison to 
the healthy, plump cylindrical control cells. The damaged cell were wrinkled and flaky 
with indented cell walls as seen in the image below (figure 46). This damage was also 
observed in the MTT OD reading which decreased from 2.727 in the untreated control to 
the 0.081.     
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Figure 46. Biofilm sample treated with 4mg/mL aspirin and 5μg/mL clarithromycin. MTT OD reading of 0.081 
at 570nm. 
EDTA (at a concentration of 8mg/mL) produced the sample formation of “fibres” 
between cells, as did 5μg/mL cefoxitin (figure 47). The addition of antibiotics to EDTA 
increased the formation of the “fibres” between M. avium cells within the biofilm as 
seen below (figures 48, 49 and 50). 
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Figure 47. M. avium biofilm sample treated with 8mg/mL EDTA. MTT OD reading of 2.622 at 570nm. Note 
the fibre-like formation between the cells. 
 
Figure 48. M. avium biofilm sample treated with 8mg/mL EDTA and 5μg/mL clarithromycin. MTT OD reading 
of 1.747 at 570nm. Note the fibre-like formation between the cells. 
102 
 
 
 
Figure 49. M. avium biofilm sample treated with 8mg/mL EDTA and 5μg/mL cefoxitin. MTT OD reading of 
1.656 at 570nm. Note the fibre-like formation between the cells. 
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Figure 50. M. avium biofilm sample treated with 8mg/mL EDTA and 5μg/mL ciprofloxicin. MTT OD reading of 
1.524 at 570nm. Note the fibre-like formation between the cells. 
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In contrast to these images, figure 51 shows the biofilm sample treated with 4mg/mL 
aspirin as well as 8mg/mL of EDTA showed no “fibres” forming between the individual 
cells, as seen in the previous figures 48, 49, and 50. However, although the cells remain 
intact as seen in figure 51 below, the MTT analysis shows complete sterilization of the 
mature M. avium biofilm (OD reading of 0.037). The sterilization of mature M. avium 
biofilms with 4mg/mL aspirin and 8mg/mL EDTA is replicated with the addition of 
5μg/mL of clarithromycin, cefoxitin or ciprofloxacin (MTT OD absorbance values of 
0.055, 0.022 and 0.004 respectively).  
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Figure 51. Two SEM images showing M. avium biofilm samples treated with 4mg/mL aspirin and 8mg/mL 
EDTA. MTT OD reading of 0.037 at 570nm. Note the lack of fibre-like formation between the cells. 
This sterilization was not observed in the sample which had a decreased concentration 
of aspirin (0.4mg/mL), and effect of aspirin on the M. avium biofilm was reduced. MTT 
OD absorbance values increased from 0.037 in the 4mg/mL aspirin and 8mg/mL EDTA 
sample to 1.746 in the 0.4mg/mL aspirin and 8mg/mL EDTA sample. This shows that 
aspirin, not EDTA, is the main effector on mature M. avium biofilm metabolism.  
 
3.10 qRT-PCR 
Furthermore, RNA from planktonic, biofilm and biofilm treated with aspirin was isolated, 
and used for downstream analysis. 
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3.10.1 RNA Quality 
RNA quality was measured on Thermo Fischer Scientific ™ Nanodrop 2000™ 
Spectrophotometer. Total RNA quality was suitable for downstream applications, as 
shown in table 15 below.   
Table 15. Total RNA quality and concentration after RNA extraction was performed on the three isolate 6 
samples. 
Sample 260/280 230/260 Concentration ng/μL 
Planktonic 2.03 1.75 66.1 
Biofilm 2.03 1.91 72.7 
Aspirin-treated Biofilm 2.02 1.9 115.8 
 
3.10.2 qRT-PCR Results 
All three total RNA samples were run on Corbett Life Science Roto-Gene 6000, with four 
primer sets (Gtf, MAI, Tmpt1 and Tmpt2). Tmpt1 showed the most significant down 
regulation compared to the other primer sets, however the MAI primer sets that were 
used as a housekeeping gene was not suitable (as seen below in the differences in cycle 
number shown in table 16 and in figure 52).   
Table 16. qRT-PCR cycle Results. Results denoted with an asterisk show significant increase in copy number.  
Primer Sets Sample Cycle Repeat at 80°C 
 Planktonic Biofilm Aspirin 
MAI 25.35 26.37 25.15 
Gtf 25.35 25.07 23.3 
Tmpt1 15.58 15.58 12.31* 
Tmpt2 17.76 18.23 15.27 
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These PCR products were then run out onto an agarose gel, using the gel-
electrophoresis and gel imaging protocols outlined in chapter 2 section 2.7 and seen 
below in figure 52. 
 
Figure 52.  Gel electrophoresis photo showing the resulting products of four primer sets after qRT-PCR had 
been performed from isolated RNA. N stands for the negative control; P denotes RNA isolated from 
planktonic cells; B stands for RNA isolated from biofilms; A denotes the RNA isolated from biofilms treated 
with aspirin. 
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Chapter Four 
4. Discussion  
 
The main objective of this study was to explore the antibiotic resistance of M. avium 
isolates obtained from the Waikato Hospital and to determine any synergy between 
antibiotics and potential biofilm dispersing agents. This is important due to the nature of 
MAC infections, and their potential to cause chronic illness, and required intensive and 
prolonged antibiotic treatment (Thoen et al., 1981; Ingen et al., 2012). Strains identified 
from the hospital isolate samples were either M. avium subsp. hominissuis or M. avium 
subsp. avium (as seen in figure 8). 
M. avium is slow growing (Starkova et al., 2013) which aids in the difficulty of 
successfully eradicating it from a human host. The slow metabolism provides a natural 
defence mechanism with antibiotics often targeting sites of cell replication and growth, 
such as DNA replication, or cell wall synthesis (Takayama & Kilburn, 1989: Mikusovà et 
al., 1995; Bosne-David et al., 2000; McNabe et al., 2011). This combined with the factor 
of added antibiotic resistance acquired from biofilm formation makes M. avium a 
difficult pathogen to eliminate.       
This study showed that aspirin, compared to all other antibiotics and potential biofilm 
dispersing agents, had a detrimental effect on the growth and biofilm forming 
capabilities of the M. avium isolates. In comparison to the antibiotics tested, 
concentrations of aspirin showed increased killing capability in both planktonic, newly 
formed and mature (up to three week old) biofilms.  
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4.1 Improved Cultivation of Mycobacterium avium  
Previous studies conducted on M. avium have reported culture times up to several 
weeks (Wu et al., 2009; Do et al., 2014), therefore it was important that we discovered a 
media that promoted rapid biofilm formation of M. avium isolates. BHI + Middlebrook 
7H9 media gave the best planktonic growth results for M. avium, agreeing with previous 
studies. Middlebrook 7H9 + Tween80 media however, showed prolific biofilm formation 
despite only having a 0.001 OD absorbance value at 570nm from the MTT analysis 
(compared to Middlebrook 7H9 alone with and OD absorbance value of 1.036 at 
570nm). This biofilm growth could be due to biofilms more readily forming under 
stressful, nutrient poor conditions, hence why the OD value was so low yet mature 
biofilms were observed under auramine-O methylene blue stain. This agrees with 
previous research which suggests that biofilm formation occurs under stressful, nutrient 
limited conditions (Geier et al., 2008; McNabe et al., 2011). Auramine-o methylene blue 
double stain was used due to its properties of staining acid fast bacteria, such as 
Mycobacterium species, providing a secondary check to the identification PCR, showing 
that the bacteria observed were of Mycobacterium species. Although, due to the 
addition of Tween80, which has been shown to increase antibiotic efficiency in gram-
positive bacteria, it was unable to be used in following MIC and synergy experiments 
with antibiotics. Therefore, BHI + 199 media was used instead as it gave the same 
biofilm and planktonic growth rates as BHI + Middlebrook 7H9 media but was more 
readily available. In future studies BHI + 199 media should be used for rapid M. avium 
cultivation.  
Effective cultivation was needed to provide consistent, repeatable biofilm phenotypes 
for experimentation to be conducted on. Due to these results from crystal-violet 
staining, glass coverslips were used over polystyrene to promote biofilm growth in 24 
well plates. This method was extremely successful and produced replicable results and 
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allowed efficient processing of high volumes of samples for MTT analysis, staining and 
SEM imaging.  
However, biofilms are formed in nature under nutrient-poor conditions and in mixed 
species communities (Thoen et al., 1981; Flores et al., 2005). The rapid formation of M. 
avium biofilms we were able to achieve does not fully represent MAC biofilms found in 
patients, however, it may provide a more accurate model of pulmonary MAC infections 
than planktonically grown M. avium. 
M. avium isolates grew faster on BHI+ 199 + 5% sterile horse serum agar plates 
compared to other agar medium, with colonies forming within 7 days. However, for 
sufficient growth, two week incubation was needed, which was similar to previous 
methods.   
4.2 Isolate Differences 
McNabe et al. (2011) found direct phenotypic differences in the cultivation of M. avium 
subsp. hominissuis isolates. Our findings also show clear phenotypic and susceptibility 
differences among the ten confirmed M. avium isolates, which has also been reported in 
previous studies (Freeman et al., 2006; Ingen et al., 2012). Using PCR methods from Tran 
et al. (2014) all isolates except 9, were able to be further defined into subspecies. For 
isolates 2, 5, 6, 7, 10, 11 and A, primer sets identified by Tran et al. (2014) that target the 
IS901 and IS900 regions of M. avium would be able to further identify the isolates as 
either M. avium subsp. paratuberculosis or M. avium subsp. hominissuis. Isolates are 
unlikely to be M. avium subsp. paratuberculosis as mycobactin was not included in the 
growth media. However, no similarities in antibiotic susceptibility were observed 
between isolates that were identified as being of the same subspecies- in either 
planktonic or biofilm phenotype. Biofilm phenotype was also independent of subspecies, 
shown in figure 19, isolate 8 (identified as M. avium subsp. avium via subspecies PCR) 
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shows similar biofilm growth as isolate 11 (identified as M. avium subsp. 
paratuberculosis or M. avium subsp. hominissuis via subspecies PCR) on glass coverslips. 
SAUTYPE PCR confirmed genetic difference between all of the isolates, even among 
isolates of the same subtype. This potentially gives an explanation for the differences in 
observed phenotype and antibiotic susceptibility. Isolate 1 was observed to grow in 
small micro-colonies in broth media and on the glass coverslip, never forming cohesive 
biofilms. This may explain why the dramatic effects of aspirin and other biofilm 
dispersing agents appeared insignificant against isolate 1. Isolates that appeared 
phenotypically similar, such as 2 and 7, showed some similar antibiotic susceptibility 
results, although generally the range in antibiotic susceptibility between isolates was 
extremely diverse and often differed in the most effective combination of antibiotics, 
and even concentrations. For example, what was strong against one isolate was weak 
against another (as seen in figures 26, 27, 32 and 35). Isolate 7 mature biofilms showed 
susceptibility to 10μg/mL clarithromycin, but not 5μg/mL. Isolate A mature biofilms 
showed susceptibility to 5μg/mL rifampicin, but not 5μg/mL clarithromycin, which 
conflicts with the average results (figure 30), which identify clarithromycin as the overall 
most effective antibiotic. Unfortunately this isolate diversity contributes to the difficulty 
of MAC infection treatment. Better methods for identification of M. avium sub-species 
and even genetic markers for isolate differences would greatly improve treatment by 
tailoring the therapy to specific subspecies. The idea of genetically tailored treatment 
has been discussed significantly in recent literature, however, the financial and resource 
practicality of using genetic testing in hospital diagnostics restricts its usefulness.   
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4.3 Mycobacterium avium MICs  
One of this studies aims was to identify MICs and potential antibiotic resistant strains of 
M. avium hospital isolates. Our findings show that clarithromycin was the most effective 
antibiotic against planktonic and biofilm M. avium populations, which agrees with 
previous research (Heifets, 1988; Inagaki et al., 2011). However, conversely to previous 
research, all of the isolates had MICs >15μg/mL to clarithromycin even in planktonic 
phenotype. Previous studies have identified highly resistant isolates to have >16μg/mL 
MICs to clarithromycin, although only a small percentage of their study size was highly 
resistant whereas all of the isolates tested in our research were (Meier et al., 1994; Nash 
& Inderlied, 1995; Wallace Jr et al., 1996; Park et al., 2009; Inagaki et al., 2011). This high 
number of resistant isolates agrees with our first hypothesis and could potentially be 
due to the nature of how the isolates were obtained. Isolates were collected at the 
Waikato Hospital from patients with chronic MAC infections. If samples were collected 
after a patient had previous, unsuccessful antibiotic therapy, antibiotic resistance from 
persister cells within the biofilm could have conferred their resistance to the isolate and 
thus increasing the antibiotic resistance to commonly used antibiotics. This could 
account for the level of MICs shown especially MICs >128μg/mL. History of when the 
isolates were obtained from patients during the course of treatment would be useful for 
investigating this theory.       
The method of using MTT analysis for determining bacterial growth and MICs has been 
used in previous studies (Mosmann, 1983; Mohammadzadeh et al., 2006; Primm & 
Franzblau, 2007; Singh et al., 2011; Trafny et al., 2013) and is widely accepted as a valid 
measure. In this study MTT analysis was used due to the quick result acquisition time 
frame as well as the ease of practically being able to observe the OD of samples. The 
method of MTT analysis relies on actively metabolising cells taking up the yellow, water 
soluble MTT and reducing it to an insoluble purple formazan crystal. The formazan can 
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then be dissolved in a solubilising solution which kills the cells allowing samples to be 
safely handled. The OD of the dissolved purple colouration can be measured on a 
spectrophotometer and used as a measure of cell population and growth via the level of 
metabolism (Mosmann, 1983; Mohammadzadeh et al., 2006; Primm & Franzblau, 2007; 
Singh et al., 2011; Trafny et al., 2013).  
Consistently, M. avium biofilms achieved higher absorbance values indicating more 
growth and therefore were more resistant to antibiotic treatment. No MICs could be 
determined for any antibiotics tested on M. avium biofilms. This agrees with our second 
hypothesis and previous research on increased resistance to antibiotics when the cells 
are in biofilm phenotype (Falkinham, 2007; McNabe et al., 2011). However, the increase 
in antibiotic resistance due to biofilm phenotype alone suggests that the resistance is 
physical and not genetically induced antibiotic resistance, such as what was identified in 
some true clarithromycin resistant strains of M. avium. This could also be suggested 
from our research showing a plateau effect of antibiotics on mature biofilms (figure 25, 
26 and 27). This agrees with Falkinham’s (2007) earlier research on M. avium target 
grown in catheters. All antibiotics require the ability to physically reach their action site 
within the bacterial cell in order to have an antibacterial effect. It is possible that the 
physical barrier created by the M. avium biofilm prevents the antibiotics reaching their 
targets, thus allowing more internal M. avium cells to grow unhindered.  
Interestingly, the addition of antibiotics at higher concentrations increased 
planktonically grown cells metabolism and biofilm formation. Doxycycline was 
investigated for antibiotic effectiveness as well as potential biofilm disrupting 
properties. However, the absorbance for planktonic cells grown with 25μg/mL 
doxycycline was higher than the untreated control both being above 2.0 OD absorbance 
values at 570nm. This shows that doxycycline is ineffective in the treatment of M. avium 
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potentially even increasing the growth of M. avium populations. Ingen et al. (2012) 
reported that Mycobacteria combat tetracyclines, such as doxycycline and rifampicin via 
drug efflux pumps, potentially explaining the increased growth of M. avium and 
apparent lack of effect of rifampicin, Rifinah™ and doxycycline (figure 10). Our findings 
also show a plateau effect of antibiotics on M. avium planktonic and biofilm phenotypes, 
which has not been shown for M. avium in other research (figures 9, 25, 26 and 27). 
Concentrations of antibiotics 5μg/mL to 20μg/mL showed insignificant differences in 
their ability to inhibit M. avium growth (figure 9 and 25). Furthermore the addition of 
8mg/mL cefoxitin to M. avium biofilms showed an increase across in MTT OD all isolates, 
compared to untreated control biofilms (table 10). This increase in M. avium biofilm 
growth after being treated with high doses of antibiotics agrees with previous research 
which also observed increased biofilm formation with the addition of sub inhibitory 
antimicrobials (McNabe et al., 2011). McNabe et al. (2011) suggest that this is a 
response to competition for nutrients in bacterial communities, such as biofilms. 
Bacterial cells will synthesise and release antimicrobial compounds to gain an advantage 
by killing surrounding competing cells. The increase in biofilm formation in the presence 
of sub inhibitory antimicrobials suggests that the M. avium cells are using this 
mechanism to combat the external chemical attack.  
Furthermore, McNabe et al. (2011) showed that M. avium cells that gained increased 
resistance in biofilm phenotype retained this resistance to antibiotics when dispersed 
into planktonic populations, which was not explored during our research. Clinically, this 
could be detrimental in the treatment of M. avium pulmonary infections where sub 
inhibitory concentrations of antibiotics would only further increase biofilm formation, 
thus exacerbating existing MAC infections. This further highlights the need for biofilm 
dispersing agents to be used in conjunction with antibiotics for successful treatment.    
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4.4 Antibiotic Synergy 
No secondary antibiotics were found to have significant synergistic effect on 
planktonically grown M. avium with clarithromycin, often clarithromycin alone was 
more effective than in combination with other antibiotics (figure 30, table 11). The 
addition of a tetracycline, doxycycline at 25μg/mL showed no antibiotic synergy with any 
other of the antibiotics used in this research.  
Although no significant antibiotic synergy was found during this study, the need to 
maintain multiple-drug therapy is vital, in order to prevent antibiotic resistance 
developing. 
 
4.5 Mycobacterium avium Biofilm Genes 
It is well known that M. avium forms biofilms in nature, and several studies have 
identified genes within the M. avium genome that are responsible for biofilm 
production. Several of these genes are involved in GPL biosynthesis, such as guaB2 and 
gtf, where GPL has been identified as important for initial establishment and adherence 
of early biofilms (McNabe et al., 2011).  Our findings show that in established biofilms, 
gtf doesn’t play such an important role in maintaining the biofilm phenotype. McNabe 
et al. (2011) showed that expression of guaB2 and gtf was greater when sub inhibitory 
antibiotics were added. Further research needs to be conducted into determining if gtf 
and Guab2 are also important for the dispersal of M. avium biofilms, not just formation. 
Tmpt1 and tmpt2, which are primers targeting a hypothetical SAM- dependent 
methyltransferase gene showed minimal change between samples. Tmpt1 showed a 
significant increase in the total RNA of aspirin treated M. avium sample, amplifying 
almost three cycles ahead of the biofilm and planktonic M. avium samples (table 16). 
However, the tmpt2 primer set, which was supposed to target the same gene, showed 
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variation across all three samples. This could be due to our protocol or primer design. 
Further testing would need to be carried out in order to confirm these results, and no 
conclusive judgements could be made from our findings. MAI primers, which target the 
16S-23S rRNA, ITS region, were used as a housekeeping gene for the qRT-PCR 
experiments. However, the cycle numbers were not even for every sample (table 16 and 
figure 52) indicating that it was not a good housekeeping gene. In future experiments 
more appropriate housekeeping genes should be investigated.       
4.6 Mycobacterium avium Biofilm Dispersing Agents 
Previous research has shown that M. avium pulmonary infection depends on the ability 
of the M. avium isolate to form biofilms (Freeman et al., 2006; Yamazaki et al., 2006). 
Clarithromycin at sub-inhibitory concentrations has been shown to effectively prevent 
the formation of biofilms (Carter et al., 2003), however, no research into the dispersal of 
established M. avium biofilms has been conducted. With patients showing MAC 
infection it is highly likely that establishment of biofilms within the lungs has already 
occurred. Thus any treatment to prevent the formation of biofilms, while necessary to 
prevent reinfection, do not aid in the initial eradication of the established biofilm.     
One aim of this study was to identify any biofilm dispersing agents that were effective 
on M. avium biofilms. Our findings show that previously identified potential biofilm 
dispersing agents; mannitol, N-acetyl-L-cysteine, active manuka honey, methylglyoxal 
(MGO), Lipitor®, 2,4-dinitrophenol (DNP) and EDTA; had no significant effect on 
dispersing M. avium biofilms or increasing their susceptibility to antibiotics. L-arginine 
had an adverse effect, greatly increasing biofilm formation in M. avium (figure 31). 
Conversely to previous findings, MGO (10μg/mL) had no effect on established M. avium 
biofilms, even with the addition of 5μg/mL clarithromycin, cefoxitin or ciprofloxacin. The 
MTT absorbance value of 0.798 in table 11, was most likely due to clearly observable 
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insufficient biofilm growth before the antibiotics and potential biofilm-dispersing agents 
were added. DNP, which uncouples energy producing pathways, had an effect on 
mature M. avium biofilms, approximately halving the MTT absorbance value 
(absorbance at 570nm 2.672 in untreated control decreasing to 1.379 with 10μg/mL 
DNP alone). This inhibiting effect was not significantly increased with the addition of 
antibiotics (table 11). The statin Lipitor™ also had weaker but similar pattern of effects 
as DNP. N-acetyl-cysteine (at a concentration of 4mg/mL) had adverse effects on 
planktonic cells of isolate 1 increasing the MTT OD at 570nm from 0.85 in the untreated 
control to 1.331. Mannitol was reported to reduce the antibiotic susceptibility of 
persister cells within biofilms. However, mannitol had no effect on already established 
biofilms. Potentially mannitol would have a role in eliminating persister cells after the 
biofilm is dispersed but more research would need to be conducted on M. avium 
persister cells.         
The failure of all the previously identified potential biofilm dispersers tested in this 
research could be due to the limitations of fully exploring the necessary concentrations 
for activity against M. avium. However, due to previous studies that have also 
investigated the effect of identified biofilm disperses on less common bacteria, these 
failings could be due to the complexity of biofilm formation and QS, particularly 
between species.    
Both aspirin and ibuprofen are non-steroidal, anti-inflammatory drugs, known to be 
non-selective COX inhibitors. Previous research showed that ibuprofen caused a 
decrease biofilm formation in E. coli (Naves et al., 2010) which agrees with our findings 
on M. avium. Mature M. avium biofilms decreased with the addition of 3.6mg/mL 
concentrations of ibuprofen. Ibuprofen alone was also able to cause a decrease in 
planktonic M. avium cell population metabolism by half (figure 13), being more effective 
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than high (15μg/mL) concentrations of clarithromycin. Interestingly, a concentration of 
3.6mg/mL ibuprofen combined with a concentration of 3.6mg/mL aspirin had a weaker 
effect on planktonic M. avium cell populations than either of these compounds alone. 
Ibuprofen was shown to sterilize M. avium planktonic cells at a concentration of 
1mg/mL via TTC methods, however, FDA/EtBr showed that it was not as effective as 
3.6mg/mL aspirin. The combination of ibuprofen (at 1mg/mL) with 16μg/mL of amikacin, 
amoxicillin, cefoxitin, moxifloxacin, rifampicin and Rifinah™ weakened the effect caused 
by ibuprofen alone.  
It should be noted that the most effective form of biofilm dispersal was from physical 
disruption. However, this is not always practical in the treatment of patients and 
chemical methods needed to be explored.  
 
4.7 The Effect of Aspirin on Mycobacterium avium  
Aspirin is a non-steroidal anti-inflammatory drug, with salicylate as the active 
component (Price et al., 2000). Salicylate produces a wide range of responses in 
bacteria, dependent on the species, such as affecting the production of virulence 
factors, decreasing antibiotic resistance or causing the initiation of multiple-antibiotic 
resistant phenotypes. In the incidence of increased antibiotic resistance, it is suggested 
that salicylate alters membrane protein synthesis, leading to increased resistance in 
normally susceptible strains. In E. coli this has been linked to the decrease in membrane 
porins and an increase in multi-drug efflux pump synthesis (Price et al., 2000). S. aureus 
also showed increased fluroquinolone resistance (such as ciprofloxacin and 
moxifloxacin) with the addition of salicylate. However, research has also shown an 
increased susceptibility to aminoglycosides in both E. coli and Klebsiella pneumoniae (K. 
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pneumoniae), when grown with increased concentrations of salicylate (Price et al., 
2000).  
However, in species of the same genus as M. avium ten genes in M. tuberculosis have 
been identified in mycobactin production (mbtA to mbtJ), with mbtI being identified as 
crucial for salicylate biosynthesis (Quadri et al., 1998). M. tuberculosis produces 
siderophores such as mycobactin, which is used in the acquisition of iron. Iron is 
especially important in pathogens, often a limiting nutrient (Jurado, 1997) and is also 
implicated as being crucial for biofilm formation of many bacterial species, including M. 
avium (Islam et al., 2012). Price et al. (2000) surmised that the inhibition of siderophore 
synthesis reduced M. tuberculosis pathogenicity. Previous research also showed 
increased resistance to isoniazid and rifampicin in M. tuberculosis, in the presence of 
salicylate (Schaller et al., 2002). Denkin et al. (2005) showed that in M. tuberculosis, 
salicylate repressed gene expression of fatty acid synthesis as well as genes involved in 
transcription and translation, however gene expression of a benzoquinone 
methyltransferase was induced by salicylate (Sun et al., 2001).   
In contrast to these previous findings, our research show that planktonic M. avium cell 
populations are able to be completely sterilized with 4mg/mL aspirin, as seen with TCC 
indicator and FDA/EtBr staining (table 6 and figure 15). A concentration of 3.6mg/mL 
aspirin was more effective at causing cell death than 16μg/mL of any antibiotics tested 
in this study (figure 15). Furthermore, aspirin (at a concentration of 4mg/mL) in 
combination with EDTA (at a concentration of 8mg/mL) was able to completely 
eradicate three week old mature M. avium biofilms. This was slightly more effective 
than aspirin (4mg/mL) alone, and thus the EDTA while not a main antagonist of biofilms, 
did produce a synergistic effect with aspirin against M. avium. This agrees with the 
previous results from Al-Bakri et al. (2009) who also showed complete eradication of 
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established P. aeruginosa biofilms when 4mg/mL concentration of aspirin and 8mg/mL 
EDTA were added. P. aeruginosa is also a ubiquitous opportunistic human pathogen, 
capable of forming biofilms in the lungs of patients which can be fatal. However, unlike 
M. avium, P. aeruginosa is gram-negative, suggesting the possibility that the 
aspirin/EDTA combination acts upon a different pathway than affecting cell membrane 
structures. 
Our findings suggest that aspirin is working at a concentration dependent manner. 
Aspirins effect on M. avium planktonic and mature biofilm cell populations showed a 
decreasing effect with decreasing concentration (figure 14 and 33). This is also 
replicated when comparing the effect of 0.4mg/mL aspirin with 8mg/mL EDTA to 
4mg/mL aspirin with 8mg/mL EDTA. The effectiveness of aspirin at a 1:10 concentration 
also showed a dramatic reduction. Interestingly aspirin (at a concentration of 3.6mg/mL) 
alone, or combined with 15μg/mL clarithromycin caused significant decrease in the OD 
of planktonic M. avium isolates (figure 12). Conversely when 4mg/mL N-acetyl-L-
cysteine was combined with aspirin ( at a concentration of 3.6mg/mL) it hindered the 
inhibiting effect of aspirin on M. avium cells. Previous research has suggested several 
theories for reduced antibiotic susceptibility in biofilm phenotype. Firstly, that 
antibiotics fail to penetrate the biofilm, or that the nutrient depleted environment 
causes a massive reduction in bacterial metabolism and growth, reducing their 
susceptibility to antimicrobials. Lastly, studies have shown that biofilms matrixes of P. 
aeruginosa bind and inhibit antibiotics (Carter et al. 2006). Due to the observed 
concentration dependent manner in which aspirin works against M. avium planktonic 
and biofilm cells (table 4 and 5, figure 14), aspirin must be able to either; penetrate the 
biofilm or be actively taken up by M. avium cells. If aspirin was being inhibited, then a 
plateau effect seen with the antibiotics (figure 25, 26 and 27) should have also been 
observed for aspirin.  
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To insure that the decrease in pH was not effecting the experimental results, the aspirin 
stock was pH balanced with NaOH and HCl, to a pH of 6.5. A 1:100 1M dilution of ACES 
buffer was added to the BHI + 199 media to control any pH changes caused by the 
potential biofilm dispersing agents (table 14). Even though these steps were taken to 
eliminate the potential acidic effects on biofilms, aspirin dissolved in DMSO performed 
the same as aspirin dissolved in EtOH at pH 6.5. This suggests that acidity does not play a 
part in the eradication or sterilization of M. avium planktonic and biofilm cell 
populations. The longevity of aspirin was determined to cause permanent cell death via 
table 13. Isolate samples treated with a concentration of 4mg/mL aspirin and spread on 
BHI+ 199+ 5% horse serum agar plates after five days, did not grow and produce 
colonies. Although this time period was not long enough to show if aspirin is 
bacteriostatic or bactericidal, combined with the observed data from the FDA/EtBr 
staining after treatment with aspirin (figure 15), the high percentage of red fluorescing 
cells suggests that aspirin causes cell death, rather than having bacteriostatic action.    
Aspirin also induced a slight effect on gtf gene expression, as shown in table 16. 
However difficulty around selecting an appropriate housekeeping gene for M. avium 
qRT-PCR experiments, means that future testing needs to be completed before these 
results can be interpreted. 
 
4.8 SEM Imaging 
Scanning Electron Microscopy gave insight into the structure of M. avium biofilms, 
accurately showing their dynamic nature, with clearly visible 3D structure and channels 
through the biofilm.  
Techniques other than the ethanol dehydration-critical point drying technique used to 
prepare the M. avium biofilms for SME imaging have been identified as more effective at 
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observing biofilms. This study was limited by the techniques available, and as a result, 
the biofilm formation might not accurately be represented. Fratsei et al. (2004) report 
that samples prepared with the ethanol dehydration- critical point drying method, tend 
to strip away the outside matrix of biofilms, and accurately represent individual cells. 
Therefore the cellular damage seen was accurately represented but the true biofilm 
formation cannot be accounted for using these images. The presence of a biofilm 
surrounding the samples treated with 5μg/mL ciprofloxacin, DMSO and 5μg/mL 
clarithromycin, DMSO and 5μg/mL cefoxitin and DMSO with 5μg/mL ciprofloxacin could 
mean that the biofilm formation was at such an extent, that the ethanol dehydration-
critical point drying technique did not remove the entire biofilm. Since this aggregation 
was not observed to such an extent in the control cells, it is possible that the slight 
stresses caused by the addition of sub MIC antibiotics and DMSO enhanced the biofilm 
formation of M. avium cells.   
Unfortunately, we are unable to determine if aspirin prevents formation of the 
extracellular matrix when compared to SEM images of DMSO combined with antibiotics 
particularly. However clear cellular damage when treated with 4mg/mL is observed by 
the wrinkled, flaky and distorted cells. Cefoxitin (5μg/mL) and EDTA combined with any 
antibiotics produced the formation of fibres between the cells. This could potentially be 
the formation of M. avium biofilms. However when EDTA was combined with aspirin 
there was a clear lack of fibre-like formation between the cells. 
It is important to consider the possibility of artefacts when studying SEM images. 
Artefacts are phenomena’s that are produced during the preparation stage of SEM 
imaging. It is not yet possible to identify artefacts from observable results and is 
important to keep in mind when analysing SEM image results.  
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4.9 Limitations with this Study 
The small sample number of confirmed M. avium isolates limits the value of the 
obtained MICs for planktonically and biofilm grown isolates. A larger sample size would 
reduce error and increase the statistical significance of these findings. All isolates were 
obtained from a specific location (the Waikato region) and came from clinical sources, 
thus all isolates were obtained from patients with predominantly chronic MAC 
infections. No M. avium isolates from environmental sources were obtained. 
Susceptibility and genetic difference between isolates was not fully explored due to 
limited time and funding. MICs for isolates grown on agar could not be determined due 
to practicality and time restraints. Antibiotic synergy was also not able to be fully 
explored with antibiotic synergy titrations, however, these findings have highlighted the 
limited effect of currently used antibiotics on existing mature M. avium biofilms in 
particular.  Isolate 6 was used for its ability to form substantial biofilms, however, future 
studies should include a wide range of M. avium isolates to determine the universal 
effects of aspirin on M. avium.  
For more accurate results, the experiment investigating the longevity of aspirin should 
be extended to at least 14 days. Unfortunately due to time constraints and attention to 
other experiments, this could not be achieved in this study.   
Further investigation into the transcriptome of M. avium biofilms could not be 
completed, due to time restraints. Therefore the mechanisms behind aspirin activity 
against M. avium could not be sufficiently determined. 
Furthermore, the in vitro data obtained in this study cannot be correlated to potential in 
vivo results. The variety of body metabolism processes, and unknown site of action of 
aspirin and ibuprofen on M. avium or M. avium biofilms means that these findings may 
not corroborate with in vivo results. 
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Chapter Five 
5. Future Recommendations  
 
Future treatment of this disease needs to focus on the eradication of the biofilm in the 
patient. Physical disruption via physiotherapy and use of biofilm dispersing agents would 
improve the action of antibiotics and the host immune system in killing M. avium 
infection.  
Biofilm preparation for SEM imaging should be prepared in a variety of techniques to 
better preserve the biofilm and reduce bias caused by certain techniques, such as 
critical-point drying (Fratesi et al., 2004), which was used in this study. This would 
ensure more accurate imaging of M. avium biofilms as they exist in nature, and give 
more insight into their physical development and structure.  
Further investigation into potential synergistic effects between antibiotics and biofilm 
dispersing agents against mature biofilms is needed.  
Investigation into the physiological pathways that aspirin and ibuprofen affect, by the 
use of transcriptomics would help identify potential new targets for the development of 
antibiofilm drugs. Better housekeeping genes need to be identified for the use in future 
qRT-PCR experimentation.   
Although aspirin shows potential in vitro, it’s effectiveness against MAC infections in vivo 
needs to be determined.  
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Chapter Six 
6. Conclusion 
 
This research provides evidence that aspirin and ibuprofen are both effective against 
planktonic and existing biofilm formation. Aspirin and EDTA combined was able to 
eradicate and sterilize mature (three week old) M. avium biofilms. These results are 
important due to the high level of antibiotic resistance found in both planktonic and 
biofilm M. avium isolates. 
Substances that were found to effect biofilms of other bacterial species, such as 
mannitol, N-acetyl-L-cysteine, active manuka honey, methylglyoxal, Lipitor®, 2,4-
dinitrophenol and EDTA, had no significant effect on M. avium biofilms, with some of 
these substances causing an increase in biofilm formation. None of these substances 
showed synergistic effects when combined with antibiotics.         
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Appendix One 
Buffers and Solutions 
1X PBS – phosphate buffered saline pH 7-7.4 
8g NaCl 
0.25g KCl 
0.2g KH2PO4 
1.15g Na2HPO4 
Adjust with NaOH or HCl to pH 7-7.4 
Make up to 1L with sterile mQH2O. 
0.1% DEPC treated water - diethyl pyrocarbonate 
2mL DEPC 
Make up with 2L mQH2O, 
Mix overnight using magnetic stirrer  
Autoclave 
2,3,5 Triphenyl Tetrazolium Chloride (TTC) 
0.5g powder into 10mL sterile mQH2O = Stock solution of 50mg/mL 
Filter steralise through a 0.22μm filter 
Store at -20°C in darkness 
6X agarose gel loading buffer 
3mL Glycerol 
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25mg Bromophenol Blue  
20μl Xylene Cyanole 
Make up to 10mL with sterile mQH2O 
 
PEG – polyethyleneglycol potassium hydroxide pH 13.3-13.5 
27mL PEG 200 
465μl 2M KOH 
Adjust with NaOH or HCl to pH 13.3-13.5 
Make up to 50mL with sterile mQH2O 
5mg/mL MTT Solution 
0.05g MTT 
Make up to 10mL with sterile PBS pH 7.2 
20% SDS 50% DMF MTT Solubilizing Solution pH 4.7 
10g SDS 
25mL DMF 
Make up to 50mL with sterile mQH2O 
Adjust with HCl or NaOH to pH 4.7 
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BHI + 199 + ACES Buffer Media Recipe 
6mL Glycerol 
7.4g Brain Heart Infusion Media 
1.92g 199 Media 
Adjust with NaOH or HCl to pH 6.5 
Make up to 200mL sterile mQH2O 
Autoclave 
 
Columbia Media 
6mL Glycerol 
7.4g Brain Heart Infusion Media 
8.8g Columbia Media 
Adjust with NaOH or HCl to pH 6.5 
Make up to 200mL sterile mQH2O 
Autoclave 
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Middlebrook 7H9 Media 
6mL Glycerol 
7.4g Brain Heart Infusion Media 
1g Middlebrook 7H9 Media 
Adjust with NaOH or HCl to pH 6.5 
Make up to 200mL sterile mQH2O 
Autoclave 
Acid Alcohol Methylene Blue Counter Stain 
0.2g Methylene Blue 
0.5mL Concentrated HCl 
74mL 95% EtOH 
26mL sterile mQH2O 
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Appendix Two 
Antibiotic Calculations 
Amoxicillin  
0.1g + 10mL sterile mQH2O = Stock solution of 10mg/mL 
0.1mL of 10mg/mL Amoxicillin stock + 0.9mL sterile mQH2O = 1mg/mL Amoxicillin 
Clarithromycin 
0.1g + 10mL sterile mQH2O = Stock solution of 10mg/mL 
0.1mL of 10mg/mL Clarithromycin stock + 0.9mL sterile mQH2O = 1mg/mL 
Clarithromycin 
Doxycycline 
0.1g + 10mL sterile mQH2O = Stock solution of 10mg/mL 
0.1mL of 10mg/mL Doxycycline stock + 0.9mL sterile mQH2O = 1mg/mL Doxycycline 
Cefoxitin 
0.1g + 10mL sterile mQH2O = Stock solution of 10mg/mL 
0.1mL of 10mg/mL Cefoxitin stock + 0.9mL sterile mQH2O = 1mg/mL Cefoxitin 
Amikacin 
500mg + 2.5mL sterile mQH2O = Stock solution of 250mg/mL 
0.4mL of 250mg/mL Amikacin stock + 0.96mL sterile mQH2O = 10mg/mL Amikacin 
0.1mL of 10mg/mL Amikacin stock + 0.9mL sterile mQH2O = 1mg/mL Amikacin 
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Ciprofloxacin 
200mg/mL + 100mL sterile mQH2O = Stock solution of 2mg/mL 
0.5mL of 2mg/mL Ciprofloxacin stock + 0.5mL sterile mQH2O = 1mg/mL Ciprofloxacin 
Ethambutol 
One 400mg tablet + 8mL sterile mQH2O = Stock solution of 50mg/mL 
0.2mL of 10mg/mL Ethambutol stock + 0.8mL sterile mQH2O = 1mg/mL Ethambutol 
Rifinah ™ 
Six 150mg/mL tablets + 9mL sterile DMSO = Stock solution of 100mg/mL 
0.1mL of 10mg/mL Rifinah™ stock + 0.9mL sterile mQH2O = 1mg/mL Rifinah™ 
Moxifloxacin 
One 400mg tablet + 8mL sterile DMSO = Stock solution of 50mg/mL 
0.2mL of 10mg/mL Moxifloxacin stock + 0.8mL sterile mQH2O = 1mg/mL Moxifloxacin 
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Appendix Three 
Biofilm Dispersing Agents Recipes  
 
Aspirin (Acetylsalicylic Acid) 
1.0g + 10mL sterile EtOH = Stock solution of 100mg/mL 
Adjust pH to 6.5 with NaOH or HCl 
EDTA 
1.0g + 10mL sterile mQH2O = Stock solution of 100mg/mL 
Ibuprofen 
1.0g + 10mL sterile mQH2O = Stock solution of 100mg/mL 
Mannitol 
1.8217g +10mL sterile mQH2O = Stock solution of 1M mannitol 
Manuka Honey 
2.0g +10mL sterile mQH2O = Stock solution of 20% manuka honey 
N- acetyl-L-cysteine 
1.0g +10mL sterile mQH2O = Stock solution of 100mg/mL 
 
